⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chloroform SCHEMBL7827442 | 1.00 | ALDH1A1 (0.46) | — | |
| Chloroform SCHEMBL613360 | 1.00 | — | — | |
| Chloroform SCHEMBL9236775 | 1.00 | ALDH1A1 (0.46) | — | |
| Chloroform SCHEMBL9230061 | 1.00 | ALDH1A1 (0.46) | — | |
| Chloroform SCHEMBL27708536 | 0.91 | ALDH1A1 (0.40) | — | |
| Chloroform SCHEMBL7008332 | 0.91 | — | — | |
| Chloroform SCHEMBL27652357 | 0.88 | ALDH1A1 (0.38) | — | |
| Chloroform SCHEMBL6069764 | 0.88 | CYP3A4 (0.38) | — | |
| Acetonitrile SCHEMBL365119 | 0.86 | — | — | |
| Isopropyl Alcohol SCHEMBL10462689 | 0.84 | ALDH1A1 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 633 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117343019-A | Preparation method of 4, 7-diazaspiro [2.5] octane-4-tert-butyl formate | 焦作市沃恩生物科技有限责任公司 | 2024-01-05 | — | — | CN | claimed |
| WO-2023236797-A1 | HANGTAIMYCIN DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 武汉大学 | 2023-12-14 | — | — | WO | claimed |
| CN-116836115-A | Hydrazine naphthalimide functionalized column [5] arene, supermolecule assembly, thin film sensor, and preparation methods and applications thereof | 河北师范大学 | 2023-10-03 | — | — | CN | claimed |
| CN-115819472-A | Polypyridine metal complex and preparation method thereof | 广州大学 | 2023-03-21 | — | — | CN | claimed |
| CN-114773266-B | Improved synthesis method of montelukast sodium | 牡丹江恒远药业股份有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-114773266-A | Improved synthesis method of montelukast sodium | 牡丹江恒远药业股份有限公司 | 2022-07-22 | — | — | CN | claimed |
| CN-114252310-A | Sample preparation method for detecting 26 pesticide residues in royal jelly | 黄华 | 2022-03-29 | — | — | CN | claimed |
| CN-113624889-A | Method for detecting 26 pesticide residues in royal jelly | 衢州市食品药品检验研究院(衢州市医疗器械质量监督检验所) | 2021-11-09 | — | — | CN | claimed |
| CN-108576313-A | A kind of auxiliary prevents health protection tea and preparation method and the detection method of nonalcoholic fatty liver | 河南牧业经济学院 | 2018-09-28 | — | — | CN | claimed |
| CN-107873515-A | A kind of blue tissue culture and rapid propagation method of spot tongue | 秦素梅 | 2018-04-06 | — | — | CN | claimed |
| CN-107837304-A | A kind of method that antimicrobial component is extracted from cape jasmine | 程志鹏 | 2018-03-27 | — | — | CN | claimed |
| CN-107593896-A | A kind of strawberry preservative and preparation method thereof | 程志鹏 | 2018-01-19 | — | — | CN | claimed |
| CN-104288141-B | A kind of simvastatin solid composite medicament and preparation method thereof | 河南科技大学 | 2016-08-24 | — | — | CN | claimed |
| CN-105628761-A | Malachite green voltammetric sensor based on imprinting recognition as well as preparation method and application thereof | UNIV NANHUA | 2016-06-01 | — | — | CN | claimed |
| CN-104860873-A | Preparation method for (S)-1,4-dihydropyridine calcium ion antagonist | UNIV SHIJIAZHUANG | 2015-08-26 | — | — | CN | claimed |
| CN-104478921-A | Intermediate Mb of calcipotriol and separation and detection method of impurities thereof | CHONGQING HUAPONT PHARM CO LTD | 2015-04-01 | — | — | CN | claimed |
| CN-104288141-A | Simvastati-containing solid medicinal composition and its preparation method | UNIV HENAN SCIENCE & TECH | 2015-01-21 | — | — | CN | claimed |
| CN-102827177-A | Method for preparing henningsoline | NANJING ZELANG MEDICAL TECH CO | 2012-12-19 | — | — | CN | claimed |
| US-5631362-A | FORMING DNA AND RNA BY POLYCONDENSATION OF MONONUCLEOTIDES WITH PROTECTIVE SULFONYLALKYL DIMETHYLAMINONAPHTHALENE GROUPS FOR ALKOXY FURAN GROUPS | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-05-20 | — | — | US | claimed |
| US-6391949-B1 | — | — | None | — | — | US | disclosed |
| US-20240239833-A1 | ALKOXYPHENYL DERIVATIVES, PROTECTED NUCLEOSIDES AND PROTECTED NUCLEOTIDES, METHOD FOR PRODUCING OLIGONUCLEOTIDES, AND METHOD FOR REMOVING SUBSTITUENTS | FUJIMOTO CHEMICALS CO., LTD., (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20240239834-A1 | ALKOXYPHENYL DERIVATIVES, PROTECTED NUCLEOSIDES AND PROTECTED NUCLEOTIDES, METHOD FOR PRODUCING OLIGONUCLEOTIDES, AND METHOD FOR REMOVING SUBSTITUENTS | FUJIMOTO CHEMICALS CO., LTD., (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20240244887-A1 | Method For Manufacturing Display Device, Display Device, Display Module, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20240230607-A9 | FINGERPRINT SPECTRUM CONSTRUCTION METHOD FOR XIHUANG CAPSULES AND FINGERPRINT SPECTRUM | SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2024-07-11 | — | — | US | disclosed |
| US-20240228478-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. | 2024-07-11 | — | — | US | disclosed |
| CN-118221930-A | Amphiphilic triblock copolymer, preparation method thereof and nanoparticles thereof | 中国海洋大学 | 2024-06-21 | — | — | CN | disclosed |
| CN-118215466-A | Oral Abiraterone formulation | 普洛佩拉治疗公司 | 2024-06-18 | — | — | CN | disclosed |
| US-20240189244-A1 | COMPOSITIONS AND METHODS FOR DELIVERING PHARMACEUTICAL AGENTS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2024-06-13 | — | — | US | disclosed |
| US-11999727-B2 | Compounds and methods of use | TANGO THERAPEUTICS, INC. (US) | 2024-06-04 | — | — | US | disclosed |
| CN-118044536-A | Drying method of rape bolts and dried rape bolts | 中国农业科学院油料作物研究所 | 2024-05-17 | — | — | CN | disclosed |
| CN-117969695-A | Method for determining 4-aminoazobenzene in textile industry wastewater | 南京海关工业产品检测中心 | 2024-05-03 | — | — | CN | disclosed |
| US-20240133851-A1 | FINGERPRINT SPECTRUM CONSTRUCTION METHOD FOR XIHUANG CAPSULES AND FINGERPRINT SPECTRUM | UNIV SHAANXI SCIENCE & TECH (CN) | 2024-04-25 | — | — | US | disclosed |
| WO-2024052786-A1 | LIGHT-EMITTING DEVICE AND DISPLAY APPARATUS | 株式会社半導体エネルギー研究所 | 2024-03-14 | — | — | WO | disclosed |
| US-20240059689-A1 | PURINE DERIVATIVES AS ANTICANCER AGENTS | MEDIVIR AB (SE) | 2024-02-22 | — | — | US | disclosed |
| EP-4323338-A1 | TEAD INHIBITORS | Orion Corporation (FI) | 2024-02-21 | — | — | EP | disclosed |
| CN-117500786-A | TEAD inhibitors | 奥赖恩公司 | 2024-02-02 | — | — | CN | disclosed |
| CN-117425656-A | Purine derivatives as anticancer agents | 探戈医药股份有限公司 | 2024-01-19 | — | — | CN | disclosed |
| WO-2024013655-A1 | PROCESS FOR PRODUCING POLYUNSATURATED FATTY ACIDS IN THE FORM OF ESTERS | ENI S.P.A. (IT) | 2024-01-18 | — | — | WO | disclosed |
| CN-117343019-A | Preparation method of 4, 7-diazaspiro [2.5] octane-4-tert-butyl formate | 焦作市沃恩生物科技有限责任公司 | 2024-01-05 | — | — | CN | disclosed |
| US-20230414766-A1 | POLYMER-BASED MACROMOLECULAR PRODRUGS | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2023-12-28 | — | — | US | disclosed |
| WO-2023236797-A1 | HANGTAIMYCIN DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 武汉大学 | 2023-12-14 | — | — | WO | disclosed |
| US-11833256-B2 | Selective RARγ ligand-loaded nanoparticles for manipulation of targeted bone growth | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2023-12-05 | — | — | US | disclosed |
| US-11839155-B2 | Organic semiconducting compounds | RAYNERGY TEK INC. (TW) | 2023-12-05 | — | — | US | disclosed |
| CN-117120034-A | Abiraterone prodrugs | 普洛佩拉治疗公司 | 2023-11-24 | — | — | CN | disclosed |
| CN-117030868-A | Method for detecting genotoxic impurities in aripiprazole | 迪嘉药业集团股份有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-114478582-B | Conjugated fused macrocyclic material containing phenothiazine, and preparation method and application thereof | 复旦大学 | 2023-10-10 | — | — | CN | disclosed |
| CN-116836115-A | Hydrazine naphthalimide functionalized column [5] arene, supermolecule assembly, thin film sensor, and preparation methods and applications thereof | 河北师范大学 | 2023-10-03 | — | — | CN | disclosed |
| US-11752165-B2 | Basic chemotherapeutic intratumour injection formulation | US Nano Food & Drug, Inc (US) | 2023-09-12 | — | — | US | disclosed |
| CN-112533892-B | Alkoxyphenyl derivative, nucleoside protector, nucleotide protector, method for producing oligonucleotide, and method for removing substituent | 藤本化学制品株式会社 | 2023-09-08 | — | — | CN | disclosed |
| EP-4227296-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM Corporation (JP) | 2023-08-16 | — | — | EP | disclosed |
| CN-116568677-A | piperidin-1-yl-N-pyridin-3-yl-2-oxoacetamide derivatives useful for the treatment of MTAP deficiency and/or MTA accumulating cancers | 探戈医药股份有限公司 | 2023-08-08 | — | — | CN | disclosed |
| WO-2023146987-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023146990-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| CN-111316451-B | Photoelectric conversion element, photosensor, imaging element, and compound | 富士胶片株式会社 | 2023-07-21 | — | — | CN | disclosed |
| EP-4188920-A1 | PIPERIDIN-1-YL-N-PYRYDINE-3-YL-2-OXOACETAMIDE DERIVATIVES USEFUL FOR THE TREATMENT OF MTAP-DEFICIENT AND/OR MTA-ACCUMULATING CANCERS | Tango Therapeutics, Inc. (US) | 2023-06-07 | — | — | EP | disclosed |
| US-11655476-B2 | Modular DNA assembly system | Victoria Link Llimited (NZ) | 2023-05-23 | — | — | US | disclosed |
| US-11642414-B2 | Polymer-based macromolecular prodrugs | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2023-05-09 | — | — | US | disclosed |
| US-20230113778-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. | 2023-04-13 | — | — | US | disclosed |
| CN-113030310-B | Method for detecting carotenoid in meat and egg food by using HPLC (high performance liquid chromatography) method | 中国标准化研究院 | 2023-04-11 | — | — | CN | disclosed |
| CN-115819472-A | Polypyridine metal complex and preparation method thereof | 广州大学 | 2023-03-21 | — | — | CN | disclosed |
| EP-4135686-A1 | BASIC CHEMOTHERAPEUTIC INTRATUMOUR INJECTION FORMULATION | US Nano Food & Drug Inc (US) | 2023-02-22 | — | — | EP | disclosed |
| US-11569450-B2 | Photoelectric conversio element, optical sensor, imaging element, and compound | FUJIFILM CORPORATION (JP) | 2023-01-31 | — | — | US | disclosed |
| WO-2023002316-A1 | DISPLAY DEVICE AND METHOD FOR MANUFACTURING DISPLAY DEVICE | 株式会社半導体エネルギー研究所 | 2023-01-26 | — | — | WO | disclosed |
| CN-115575542-A | Fingerprint construction method and fingerprint of Xihuang capsule | 陕西科技大学 | 2023-01-06 | — | — | CN | disclosed |
| EP-3888150-B1 | PHOTOACTIVE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2023-01-04 | — | — | EP | disclosed |
| CN-114773266-B | Improved synthesis method of montelukast sodium | 牡丹江恒远药业股份有限公司 | 2022-12-27 | — | — | CN | disclosed |
| CN-115427063-A | TLR7 agonists | 普利缪尼治疗学股份有限公司 | 2022-12-02 | — | — | CN | disclosed |
| CN-115403574-A | Preparation method of rauwolfine hydrochloride | 李玉山 | 2022-11-29 | — | — | CN | disclosed |
| WO-2022219246-A1 | TEAD INHIBITORS | ORION CORPORATION (FI) | 2022-10-20 | — | — | WO | disclosed |
| US-20220320445-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | RAYNERGY TEK INC. (TW) | 2022-10-06 | — | — | US | disclosed |
| CN-114773266-A | Improved synthesis method of montelukast sodium | 牡丹江恒远药业股份有限公司 | 2022-07-22 | — | — | CN | disclosed |
| US-20220160886-A1 | POLYMER-BASED MACROMOLECULAR PRODRUGS | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2022-05-26 | — | — | US | disclosed |
| CN-114478582-A | Conjugated condensed macrocyclic material containing phenothiazine, and preparation method and application thereof | 复旦大学 | 2022-05-13 | — | — | CN | disclosed |
| US-20220127256-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. | 2022-04-28 | — | — | US | disclosed |
| CN-114252310-A | Sample preparation method for detecting 26 pesticide residues in royal jelly | 黄华 | 2022-03-29 | — | — | CN | disclosed |
| US-11253603-B2 | Polymer-based macromolecular prodrugs | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2022-02-22 | — | — | US | disclosed |
| WO-2022026892-A1 | PIPERIDIN-1- YL-N-PYRYDI NE-3-YL-2-OXOACET AM IDE DERIVATIVES USEFUL FOR THE TREATMENT OF MTAP-DEFICIENT AND/OR MT A-ACCUMULATING CANCERS | TANGO THERAPEUTICS, INC. (US) | 2022-02-03 | — | — | WO | disclosed |
| US-20210395271-A1 | COMPOSITION FOR EL DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-12-23 | — | — | US | disclosed |
| US-20210395272-A1 | PHOTOACTIVE COMPOUND | SUMITOMO CHEMICAL CO., LTD. (JP) | 2021-12-23 | — | — | US | disclosed |
| US-20210388337-A1 | PROTEIN-POLYMER CONJUGATES AND METHODS FOR THEIR PREPARATION | CARNEGIE MELLON UNIVERSITY | 2021-12-16 | — | — | US | disclosed |
| US-11171165-B2 | Photoelectric conversion element, imaging element, optical sensor comprising a photoelectric conversion film containing a predetermined compound, and compound | FUJIFILM CORPORATION (JP) | 2021-11-09 | — | — | US | disclosed |
| CN-113624889-A | Method for detecting 26 pesticide residues in royal jelly | 衢州市食品药品检验研究院(衢州市医疗器械质量监督检验所) | 2021-11-09 | — | — | CN | disclosed |
| WO-2021211294-A1 | BASIC CHEMOTHERAPEUTIC INTRATUMOUR INJECTION FORMULATION | US Nano Food & Drug INC (US) | 2021-10-21 | — | — | WO | disclosed |
| CN-113512182-A | PBS (Poly Butylene succinate) resin composition and preparation method thereof | 万华化学集团股份有限公司 | 2021-10-19 | — | — | CN | disclosed |
| US-20210317159-A1 | ALKOXYPHENYL DERIVATIVES, PROTECTED NUCLEOSIDES AND PROTECTED NUCLEOTIDES, METHOD FOR PRODUCING OLIGONUCLEOTIDES, AND METHOD FOR REMOVING SUBSTITUENTS | FUJIMOTO CHEMICALS CO., LTD. (JP) | 2021-10-14 | — | — | US | disclosed |
| US-20210315913-A1 | BASIC CHEMOTHERAPEUTIC INTRATUMOUR INJECTION FORMULATION | US Nano Food & Drug, Inc (US) | 2021-10-14 | — | — | US | disclosed |
| EP-3888150-A1 | PHOTOACTIVE COMPOUND | Sumitomo Chemical Co., Ltd (JP) | 2021-10-06 | — | — | EP | disclosed |
| CN-113169281-A | Photoactive compounds | 住友化学株式会社 | 2021-07-23 | — | — | CN | disclosed |
| CN-113030310-A | Method for detecting carotenoid in meat and egg food by using HPLC (high performance liquid chromatography) method | 中国标准化研究院 | 2021-06-25 | — | — | CN | disclosed |
| CN-112996533-A | Polymer-based macromolecular prodrugs | 费城儿童医院 | 2021-06-18 | — | — | CN | disclosed |
| US-11021598-B2 | Resin molded product, laminate, and decorative sheet | TOPPAN PRINTING CO., LTD. (JP) | 2021-06-01 | — | — | US | disclosed |
| CN-109053721-B | Preparation method of medicinal scopolamine butylbromide | 广州白云山汉方现代药业有限公司 | 2021-03-23 | — | — | CN | disclosed |
| CN-108872106-B | Method for measuring trace sulfite in water body | 电子科技大学 | 2021-03-19 | — | — | CN | disclosed |
| CN-112533892-A | Alkoxyphenyl derivative, nucleoside protector and nucleotide protector, method for producing oligonucleotide, and method for removing substituent | 藤本化学制品株式会社 | 2021-03-19 | — | — | CN | disclosed |
| US-20210070770-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | RAYNERGY TEK INC (TW) | 2021-03-11 | — | — | US | disclosed |
| EP-3780127-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM Corporation (JP) | 2021-02-17 | — | — | EP | disclosed |
| US-20210032635-A1 | MODULAR DNA ASSEMBLY SYSTEM | VICTORIA LINK LIMITED (NZ) | 2021-02-04 | — | — | US | disclosed |
| CN-107782805-B | HPLC analysis method for key intermediate impurity synthesized by dipyridamole | 亚宝药业集团股份有限公司 | 2021-02-02 | — | — | CN | disclosed |
| US-20210000967-A1 | POLYMER-BASED MACROMOLECULAR PRODRUGS | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2021-01-07 | — | — | US | disclosed |
| US-20200411569-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2020-12-31 | — | — | US | disclosed |
| EP-3750910-A1 | TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | VIIV Healthcare UK(No.4) Limited (GB) | 2020-12-16 | — | — | EP | disclosed |
| US-10842816-B2 | Compositions and methods for isolating and enriching IgM-producing cells and uses thereof | TRUSTEES OF BOSTON UNIVERSITY (US) | 2020-11-24 | — | — | US | disclosed |
| US-20200360404-A1 | TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY | 2020-11-19 | — | — | US | disclosed |
| CN-111868951-A | Photoelectric conversion element, imaging element, photosensor, and compound | 富士胶片株式会社 | 2020-10-30 | — | — | CN | disclosed |
| US-20200337311-A1 | FLUORALKENYL COMPOUNDS, PROCESS FOR PREPARATION AND USE THEREOF | PI INDUSTRIES LTD. (IN) | 2020-10-29 | — | — | US | disclosed |
| EP-3728204-A1 | FLUORALKENYL COMPOUNDS, PROCESS FOR PREPARATION AND USE THEREOF | PI Industries Ltd. (IN) | 2020-10-28 | — | — | EP | disclosed |
| CN-111732825-A | Antibacterial polycarbonate plastic | 智科通用技术研究(广州)有限公司 | 2020-10-02 | — | — | CN | disclosed |
| US-20200299700-A1 | HETEROLOGOUS BIOSYNTHESIS OF NODULISPORIC ACID | VICTORIA LINK LIMITED (NZ) | 2020-09-24 | — | — | US | disclosed |
| US-10780102-B2 | Triterpenoids with HIV maturation inhibitory activity | VIIV HEALTHCARE UK (NO. 4) LIMITED (GB) | 2020-09-22 | — | — | US | disclosed |
| CN-111670180-A | Fluoroalkenyl compounds, process for their preparation and their use | PI工业有限公司 | 2020-09-15 | — | — | CN | disclosed |
| US-20200266359-A1 | PHOTOELECTRIC CONVERSIO ELEMENT, OPTICAL SENSOR, IMAGING ELEMENT, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2020-08-20 | — | — | US | disclosed |
| EP-3688174-A1 | HETEROLOGOUS BIOSYNTHESIS OF NODULISPORIC ACID | Victoria Link Limited (NZ) | 2020-08-05 | — | — | EP | disclosed |
| EP-3129392-B1 | TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY, SUBSTITUTED IN POSITION 3 BY A NON-AROMATIC RING CARRYING A HALOALKYL SUBSTITUENT | VIIV HEALTHCARE UK NO 4 LTD (GB) | 2020-08-05 | — | — | EP | disclosed |
| CN-111449068-A | Mixed herbicide for corn field and preparation process thereof | 侨昌现代农业有限公司 | 2020-07-28 | — | — | CN | disclosed |
| US-20200197321-A1 | Selective RARy Ligand-loaded nanoparticles for manipulation of targeted bone growth | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 2020-06-25 | — | — | US | disclosed |
| CN-111316451-A | Photoelectric conversion element, photosensor, imaging element, and compound | 富士胶片株式会社 | 2020-06-19 | — | — | CN | disclosed |
| CN-109374773-B | Analysis method of panda fecal metabolome | 重庆医科大学 | 2020-05-22 | — | — | CN | disclosed |
| US-20200048445-A1 | RESIN MOLDED PRODUCT, LAMINATE, AND DECORATIVE SHEET | TOPPAN PRINTING CO., LTD. (JP) | 2020-02-13 | — | — | US | disclosed |
| WO-2020017085-A1 | ALKOXYPHENYL DERIVATIVE, NUCLEOSIDE PROTECTOR, NUCLEOTIDE PROTECTOR, METHOD FOR PRODUCING OLIGONUCLEOTIDE, AND METHOD FOR REMOVING SUBSTITUENT | 藤本化学製品株式会社 | 2020-01-23 | — | — | WO | disclosed |
| CN-107266937-B | Surface-functionalized nano particle | 纳米技术有限公司 | 2019-11-12 | — | — | CN | disclosed |
| CN-110358058-A | A kind of organic photoelectrical material and preparation method thereof, luminescent device and display device | 武汉轻工大学 | 2019-10-22 | — | — | CN | disclosed |
| WO-2019189134-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2019-10-03 | — | — | WO | disclosed |
| US-20190151336-A1 | TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY | 2019-05-23 | — | — | US | disclosed |
| CN-105628761-B | Malachite green voltammetric sensor based on print identification and the preparation method and application thereof | 南华大学 | 2019-05-03 | — | — | CN | disclosed |
| WO-2019064243-A1 | HETEROLOGOUS BIOSYNTHESIS OF NODULISPORIC ACID | VICTORIA LINK LIMITED (NZ) | 2019-04-04 | — | — | WO | disclosed |
| US-10245275-B2 | Triterpenoids with HIV maturation inhibitory activity | VIIV HEALTHCARE UK (NO. 4) LIMITED (GB) | 2019-04-02 | — | — | US | disclosed |
| US-20180369384-A1 | COMPOSITIONS FOR NUCLEIC ACID DELIVERY | ARBUTUS BIOPHARMA CORPORATION (CA) | 2018-12-27 | — | — | US | disclosed |
| WO-2018237004-A1 | SELECTIVE RARy LIGAND-LOADED NANOPARTICLES FOR MANIPULATION OF TARGETED BONE GROWTH | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2018-12-27 | — | — | WO | disclosed |
| CN-109053721-A | A kind of preparation method of medicinal scopolamine butylbromide | 广州白云山汉方现代药业有限公司 | 2018-12-21 | — | — | CN | disclosed |
| US-10125337-B2 | Branched diesters and methods of making and using the same | TRENT UNIVERSITY (CA) | 2018-11-13 | — | — | US | disclosed |
| CN-108576313-A | A kind of auxiliary prevents health protection tea and preparation method and the detection method of nonalcoholic fatty liver | 河南牧业经济学院 | 2018-09-28 | — | — | CN | disclosed |
| CN-106117558-B | A kind of method for separating and detecting of pyrimethamine | 佛山科学技术学院 | 2018-08-28 | — | — | CN | disclosed |
| CN-108369993-A | Composition and the light-emitting component for having used it | 住友化学株式会社 | 2018-08-03 | — | — | CN | disclosed |
| CN-108292709-A | Light-emitting component | 住友化学株式会社 | 2018-07-17 | — | — | CN | disclosed |
| CN-108219509-A | For the new compound of carrying body | 株式会社艾迪科 | 2018-06-29 | — | — | CN | disclosed |
| US-10000442-B2 | Certain metathesized natural oil triacylglycerol polyols for use in polyurethane applications and their related properties | TRENT UNIVERSITY (CA) | 2018-06-19 | — | — | US | disclosed |
| US-10000724-B2 | Metathesized triacylglycerol green polyols from palm oil for use in polyurethane applications and their related properties | TRENT UNIVERSITY (CA) | 2018-06-19 | — | — | US | disclosed |
| US-10000601-B2 | Metathesized triacylglycerol polyols for use in polyurethane applications and their related properties | TRENT UNIVERSITY (CA) | 2018-06-19 | — | — | US | disclosed |
| CN-108137554-A | Dicyanopyrazine compound, light-emitting material, light-emitting element using the light-emitting material, and method for producing 2, 5-dicyano-3, 6-dihalopyrazine | 国立大学法人九州大学 | 2018-06-08 | — | — | CN | disclosed |
| US-9982002-B2 | Sulfoxidation catalysts and methods for their preparation and use | INDIAN INSTITUTE OF TECHNOLOGY MADRAS (IN) | 2018-05-29 | — | — | US | disclosed |
| CN-107873515-A | A kind of blue tissue culture and rapid propagation method of spot tongue | 秦素梅 | 2018-04-06 | — | — | CN | disclosed |
| CN-104769045-B | carrier and photoelectric conversion element | 株式会社艾迪科 | 2018-04-03 | — | — | CN | disclosed |
| CN-107837304-A | A kind of method that antimicrobial component is extracted from cape jasmine | 程志鹏 | 2018-03-27 | — | — | CN | disclosed |
| CN-107837304-A | A kind of method that antimicrobial component is extracted from cape jasmine | 程志鹏 | 2018-03-27 | — | — | CN | disclosed |
| EP-3296398-A1 | COMPOSITIONS FOR NUCLEIC ACID DELIVERY | Arbutus Biopharma Corporation (CA) | 2018-03-21 | — | — | EP | disclosed |
| CN-105473587-B | substituted pyrazolyl pyrazole derivatives and their use as herbicides | 协友株式会社 | 2018-03-13 | — | — | CN | disclosed |
| CN-107782805-A | A kind of key intermediate impurity HPLC analysis methods of Dipyridamole synthesis | 亚宝药业集团股份有限公司 | 2018-03-09 | — | — | CN | disclosed |
| CN-107593896-A | A kind of strawberry preservative and preparation method thereof | 程志鹏 | 2018-01-19 | — | — | CN | disclosed |
| CN-104478921-B | The intermediate Mb of Calcipotriol and its method for separating and assaying of impurity | 重庆华邦制药有限公司 | 2018-01-16 | — | — | CN | disclosed |
| CN-104478921-B | The intermediate Mb of Calcipotriol and its method for separating and assaying of impurity | 重庆华邦制药有限公司 | 2018-01-16 | — | — | CN | disclosed |
| US-20170340650-A1 | TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY | 2017-11-30 | — | — | US | disclosed |
| EP-2821450-B1 | COATING COMPOSITION AND COATING FILM OBTAINED FROM COATING COMPOSITION | KANEKA CORP (JP) | 2017-10-25 | — | — | EP | disclosed |
| CN-107266937-A | Surface-functionalized nano particle | 纳米技术有限公司 | 2017-10-20 | — | — | CN | disclosed |
| US-9789200-B2 | Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in the treatment of neoplasias | FIDIA FARMACEUTICI S.P.A. (IT) | 2017-10-17 | — | — | US | disclosed |
| US-9777245-B2 | Methods of fractionating metathesized triacylglycerol polyols and uses thereof | TRENT UNIVERSITY (CA) | 2017-10-03 | — | — | US | disclosed |
| CN-104174390-B | The preparation method and application of ethopabate molecular imprinted solid phase extraction cartridge | 河南科技大学 | 2017-09-08 | — | — | CN | disclosed |
| CN-107027795-A | A kind of winter wheat field annual grassy weeds herbicide and its collocation method | 安徽喜洋洋农业科技有限公司 | 2017-08-11 | — | — | CN | disclosed |
| CN-103271083-B | Multi-functional ionic liquid compositions | 阿拉巴马大学 | 2017-08-11 | — | — | CN | disclosed |
| EP-2509636-B1 | COMPOSITIONS FOR NUCLEIC ACID DELIVERY | ARBUTUS BIOPHARMA CORP (CA) | 2017-07-19 | — | — | EP | disclosed |
| CN-106954631-A | A kind of careless agent of hybrid rice compounding suppression and its production method | 安徽金培因科技有限公司 | 2017-07-18 | — | — | CN | disclosed |
| US-9687550-B2 | Compositions for nucleic acid delivery | ARBUTUS BIOPHARMA CORPORATION (CA) | 2017-06-27 | — | — | US | disclosed |
| US-9687558-B2 | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation, and their use in the pharmaceutical field | FIDIA FARMACEUTICI S.P.A. (IT) | 2017-06-27 | — | — | US | disclosed |
| US-9670121-B2 | Diphenylmethane compound | AJINOMOTO CO., INC. (JP) | 2017-06-06 | — | — | US | disclosed |
| CN-103827126-B | Novel compound and carrier for supporting the same | 株式会社艾迪科 | 2017-05-17 | — | — | CN | disclosed |
| EP-2540319-B1 | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation | FIDIA FARM SPA (IT) | 2017-05-10 | — | — | EP | disclosed |
| US-9637698-B2 | Certain dimers as crystallization depressants | TRENT UNIVERSITY (CA) | 2017-05-02 | — | — | US | disclosed |
| CN-102177095-B | Surface functionalized nanoparticles | 纳米技术有限公司 | 2017-04-26 | — | — | CN | disclosed |
| US-20170107413-A1 | Anti-icing composition driven by catalytic hydrogen generation under subzero temperatures | WANG LIANG (US) | 2017-04-20 | — | — | US | disclosed |
| US-20170056420-A1 | TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY | 2017-03-02 | — | — | US | disclosed |
| CN-106459605-A | Loading method, loaded body and photoelectric conversion element | 株式会社艾迪科 | 2017-02-22 | — | — | CN | disclosed |
| EP-3129392-A1 | TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY, SUBSTITUTED IN POSITION 3 BY A NON-AROMATIC RING CARRYING A HALOALKYL SUBSTITUENT | VIIV Healthcare UK(No.4) Limited (GB) | 2017-02-15 | — | — | EP | disclosed |
| US-9527882-B2 | Triterpenoids with HIV maturation inhibitory activity | ViiV Healthcare UK (No.4) Limited (GB) | 2016-12-27 | — | — | US | disclosed |
| CN-104053651-B | Compound and carrier carrying the compound | 株式会社艾迪科 | 2016-12-21 | — | — | CN | disclosed |
| CN-103918050-B | Dye-sensitized solar cell | 株式会社艾迪科 | 2016-12-07 | — | — | CN | disclosed |
| CN-106117558-A | A kind of method for separating and detecting of pyrimethamine | 佛山科学技术学院 | 2016-11-16 | — | — | CN | disclosed |
| US-20160312151-A1 | Methods of Fractionating Metathesized Triacylglycerol Polyols and Uses Thereof | TRENT UNIVERSITY (CA) | 2016-10-27 | — | — | US | disclosed |
| US-9472723-B2 | Deposition of semiconductor nanocrystals for light emitting devices | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2016-10-18 | — | — | US | disclosed |
| CN-105994333-A | Direct seeding rice field annual weed herbicide and processing method thereof | 安徽远景作物保护有限公司 | 2016-10-12 | — | — | CN | disclosed |
| CN-104865328-B | A kind of device of multichannel homogenate filling capillary chromatographic column | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 2016-09-28 | — | — | CN | disclosed |
| EP-1909843-B1 | ANTITUMORAL BIOCONJUGATES OF HYALURONIC ACID OR ITS DERIVATIVES OBTAINED BY INDIRECT CHEMICAL CONJUGATION, AND THEIR USE IN THE PHARMACEUTICAL FIELD | FIDIA FARMACEUTICI (IT) | 2016-09-21 | — | — | EP | disclosed |
| US-20160251388-A1 | SULFOXIDATION CATALYSTS AND METHODS FOR THEIR PREPARATION AND USE | INDIAN INSTITUTE OF TECHNOLOGY MADRAS (IN) | 2016-09-01 | — | — | US | disclosed |
| CN-104288141-B | A kind of simvastatin solid composite medicament and preparation method thereof | 河南科技大学 | 2016-08-24 | — | — | CN | disclosed |
| CN-105874550-A | Carrier and photoelectric conversion element | 株式会社艾迪科 | 2016-08-17 | — | — | CN | disclosed |
| EP-2367837-B1 | 1'-SUBSTITUTED RIBOSE 5'-POLYPHOSPHATE ANALOGS AND THEIR USE AS MODULATORS OF P2Y RECEPTOR ACTIVITY | MICRODOSE THERAPEUTX INC (US) | 2016-08-17 | — | — | EP | disclosed |
| US-20160218296-A1 | AMINE DERIVATIVES, MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME AND ORGANIC ELECTRLUMINESCENT DEVICE USING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-07-28 | — | — | US | disclosed |
| CN-103415527-B | Compound and photoelectric conversion element | 株式会社艾迪科 | 2016-06-29 | — | — | CN | disclosed |
| CN-105628761-A | Malachite green voltammetric sensor based on imprinting recognition as well as preparation method and application thereof | UNIV NANHUA | 2016-06-01 | — | — | CN | disclosed |
| US-20160129036-A1 | ADENOSINE ANALOGS AND THEIR USE | MICRODOSE THERAPEUTX INC (US) | 2016-05-12 | — | — | US | disclosed |
| CN-103893125-B | Anidulafungin nanoparticle and preparation method thereof | Hybio Pharmaceutical Co., Ltd. (CN) | 2016-04-27 | — | — | CN | disclosed |
| US-20160096304-A1 | SYSTEMS AND METHODS FOR FACILITATING THE GENERATION OF CORE-SHEATH TAYLOR CONES IN ELECTROSPINNING | PHAM QUYNH (US) | 2016-04-07 | — | — | US | disclosed |
| US-20160060198-A1 | DIPHENYLMETHANE COMPOUND | AJINOMOTO CO., INC. (JP) | 2016-03-03 | — | — | US | disclosed |
| US-9255121-B2 | Adenosine analogs and their use | MICRODOSE THERAPEUTX, INC. (US) | 2016-02-09 | — | — | US | disclosed |
| US-9243346-B2 | Process of electrospinning core-sheath fibers | ARSENAL MEDICAL, INC. (US) | 2016-01-26 | — | — | US | disclosed |
| CN-102770979-B | The manufacture method of organic semiconducting materials and field-effect transistor and field-effect transistor | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2016-01-20 | — | — | CN | disclosed |
| CN-105263945-A | Method for synthesizing saponin | YU YUE | 2016-01-20 | — | — | CN | disclosed |
| US-20150337073-A1 | METATHESIZED TRIACYLGLYCEROL POLYOLS FOR USE IN POLYURETHANE APPLICATIONS AND THEIR RELATED PROPERTIES | TRENT UNIVERSITY (CA) | 2015-11-26 | — | — | US | disclosed |
| US-20150307811-A1 | METATHESIZED TRIACYLGLYCEROL GREEN POLYOLS FROM PALM OIL FOR USE IN POLYURETHANE APPLICATIONS AND THEIR RELATED PROPERTIES | TRENT UNIVERSITY (CA) | 2015-10-29 | — | — | US | disclosed |
| CN-103193868-B | A kind of purification process of echinocandin antifungal agent anidulafungin | NCPC NEW DRUG RESEARCH AND DEVELOPMENT CO., LTD. (CN) | 2015-10-28 | — | — | CN | disclosed |
| US-9169187-B2 | Method of making peptides using diphenylmethane compound | AJINOMOTO CO., INC. (JP) | 2015-10-27 | — | — | US | disclosed |
| US-20150299099-A1 | CERTAIN METATHESIZED NATURAL OIL TRIACYLGLYCEROL POLYOLS FOR USE IN POLYURETHANE APPLICATIONS AND THEIR RELATED PROPERTIES | TRENT UNIVERSITY (CA) | 2015-10-22 | — | — | US | disclosed |
| WO-2015157483-A1 | TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY, SUBSTITUTED IN POSITION 3 BY A NON-AROMATIC RING CARRYING A HALOALKYL SUBSTITUENT | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-10-15 | — | — | WO | disclosed |
| US-20150291655-A1 | TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | VIIV HEALTHCARE UK (NO. 4) LIMITED (GB) | 2015-10-15 | — | — | US | disclosed |
| WO-2015143563-A1 | CERTAIN METATHESIZED NATURAL OIL TRIACYLGLYCEROL POLYOLS FOR USE IN POLYURETHANE APPLICATIONS AND THEIR RELATED PHYSICAL PROPERTIES | TRENT UNIVERSITY (CA) | 2015-10-01 | — | — | WO | disclosed |
| WO-2015143562-A1 | METATHESIZED TRIACYLGLYCEROL GREEN POLYOLS FROM PALM OIL FOR USE IN POLYURETHANE APPLICATIONS AND THEIR RELATED PHYSICAL PROPERTIES | TRENT UNIVERSITY (CA) | 2015-10-01 | — | — | WO | disclosed |
| CN-104865328-A | Device for multichannel homogenate filling of capillary chromatographic columns | INST RADIATION MED AMMS PLA | 2015-08-26 | — | — | CN | disclosed |
| CN-101267840-B | Antitumor bioconjugates of hyaluronic acid or derivatives thereof obtained by indirect chemical conjugation | FIDIA FARMACEUTICI | 2015-07-08 | — | — | CN | disclosed |
| CN-104693266-A | Synthetic method of saponin | YU YUE | 2015-06-10 | — | — | CN | disclosed |
| CN-103480350-B | Method for preparing molecularly imprinted polymer through silica gel surface coating | UNIV HARBIN ENG | 2015-05-20 | — | — | CN | disclosed |
| US-20150129861-A1 | ORGANIC MATERIAL FOR DEPOSITION, AND ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, DEPOSITION METHOD, AND MANUFACTURING METHOD FOR ORGANIC PHOTOELECTRONIC ONVERSION ELEMENT OBTAINED USING THE SAME | FUJIFILM CORPORATION (JP) | 2015-05-14 | — | — | US | disclosed |
| US-9029504-B2 | Fluorene compound | AJINOMOTO CO., INC. (JP) | 2015-05-12 | — | — | US | disclosed |
| CN-104478921-A | Intermediate Mb of calcipotriol and separation and detection method of impurities thereof | CHONGQING HUAPONT PHARM CO LTD | 2015-04-01 | — | — | CN | disclosed |
| CN-104478921-A | Intermediate Mb of calcipotriol and separation and detection method of impurities thereof | CHONGQING HUAPONT PHARM CO LTD | 2015-04-01 | — | — | CN | disclosed |
| CN-104288141-A | Simvastati-containing solid medicinal composition and its preparation method | UNIV HENAN SCIENCE & TECH | 2015-01-21 | — | — | CN | disclosed |
| US-20150011675-A1 | COATING COMPOSITION AND COATING FILM OBTAINED FROM COATING COMPOSITION | KANEKA CORPORATION (JP) | 2015-01-08 | — | — | US | disclosed |
| EP-2821450-A1 | COATING COMPOSITION AND COATING FILM OBTAINED FROM COATING COMPOSITION | Kaneka Corporation (JP) | 2015-01-07 | — | — | EP | disclosed |
| US-20140325899-A1 | CERTAIN DIMERS AS CRYSTALLIZATION DEPRESSANTS | TRENT UNIVERSITY (CA) | 2014-11-06 | — | — | US | disclosed |
| EP-2403027-B1 | Photoelectric conversion device and imaging device | FUJIFILM CORP (JP) | 2014-11-05 | — | — | EP | disclosed |
| EP-2279006-B1 | THERAPEUTIC USE OF PHARMACEUTICAL PREPARATIONS CONTAINING ANTITUMORAL DRUGS BOUND TO HYALURONIC ACID IN THE TREATMENT OF NEOPLASIAS | FIDIA FARMACEUTICI (IT) | 2014-10-22 | — | — | EP | disclosed |
| WO-2014164784-A1 | HDAC INHIBITOR POLYMORPHIC FORMS AND METHODS OF USE | ARNO THERAPEUTICS (US) | 2014-10-09 | — | — | WO | disclosed |
| US-8847208-B2 | Photoelectric conversion device and imaging device having decreased dark current | FUJIFILM CORPORATION (JP) | 2014-09-30 | — | — | US | disclosed |
| US-8802596-B2 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2014-08-12 | — | — | US | disclosed |
| US-20140213761-A1 | DIPHENYLMETHANE COMPOUND | AJINOMOTO CO., INC (JP) | 2014-07-31 | — | — | US | disclosed |
| CN-103893125-A | Anidulafungin nanoparticles, and preparation method thereof | SHENZHEN HYBIO PHARMACEUTICAL | 2014-07-02 | — | — | CN | disclosed |
| US-20140147951-A1 | DEPOSITION OF SEMICONDUCTOR NANOCRYSTALS FOR LIGHT EMITTING DEVICES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2014-05-29 | — | — | US | disclosed |
| US-8722934-B2 | Diphenylmethane compound | AJINOMOTO CO., INC. (JP) | 2014-05-13 | — | — | US | disclosed |
| CN-101908597-B | Photoelectric conversion device and imaging device | FUJIFILM CORP | 2014-05-07 | — | — | CN | disclosed |
| US-8697737-B2 | Raf modulators and methods of use | EXELIXIS, INC. (US) | 2014-04-15 | — | — | US | disclosed |
| US-20140046022-A1 | FLUORENE COMPOUND | AJINOMOTO CO., INC. (JP) | 2014-02-13 | — | — | US | disclosed |
| US-20140042411-A1 | METHOD FOR PURIFYING ORGANIC MATERIAL, MATERIAL FOR ORGANIC ELECTRONICS, PHOTOELECTRIC CONVERSION DEVICE, OPTICAL SENSOR, IMAGING DEVICE, AND ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2014-02-13 | — | — | US | disclosed |
| US-20140038912-A1 | ADENOSINE ANALOGS AND THEIR USE | MICRODOSE THERAPEUTX, INC. (US) | 2014-02-06 | — | — | US | disclosed |
| EP-1932841-B1 | SULFONAMIDE COMPOUND | ASAHI KASEI PHARMA CORP (JP) | 2014-01-01 | — | — | EP | disclosed |
| CN-103480350-A | Method for preparing molecularly imprinted polymer through silica gel surface coating | UNIV HARBIN ENG | 2014-01-01 | — | — | CN | disclosed |
| US-20130338210-A1 | COMPOSITIONS FOR NUCLEIC ACID DELIVERY | ALNYLAM PHARMACEUTICALS, INC. (US) | 2013-12-19 | — | — | US | disclosed |
| CN-102014966-B | Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in treatment of neoplasias | FIDIA FARMACEUTICI | 2013-11-27 | — | — | CN | disclosed |
| US-8569453-B2 | Fluorene compound | AJINOMOTO CO., INC. (JP) | 2013-10-29 | — | — | US | disclosed |
| US-8569259-B2 | Adenosine analogs and their use | MICRODOSE THERAPEUTX, INC. (US) | 2013-10-29 | — | — | US | disclosed |
| EP-2259358-B1 | Photoelectric conversion device and imaging device | FUJIFILM CORP (JP) | 2013-10-23 | — | — | EP | disclosed |
| CN-103193868-A | Purification method of echinocandins antifungal drug anidulafungin | NCPC NEW DRUG RES & DEV CO LTD | 2013-07-10 | — | — | CN | disclosed |
| EP-2036901-B1 | C-PHENYL 1-THIOGLUCITOL COMPOUND | TAISHO PHARMACEUTICAL CO LTD (JP) | 2013-05-01 | — | — | EP | disclosed |
| CN-103041402-A | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation | FIDIA FARMACEUTICI | 2013-04-17 | — | — | CN | disclosed |
| US-8415372-B2 | Sulfonamide compound | ASAHI KASEI PHARMA CORPORATION (JP) | 2013-04-09 | — | — | US | disclosed |
| US-8404285-B2 | Guava pulp composition | UNIVERSITI PUTRA MALAYSIA (MY) | 2013-03-26 | — | — | US | disclosed |
| EP-2548582-A1 | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation | Fidia Farmaceutici S.p.A. (IT) | 2013-01-23 | — | — | EP | disclosed |
| EP-2540319-A1 | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation | FIDIA FARMACEUTICI S.p.A. (IT) | 2013-01-02 | — | — | EP | disclosed |
| EP-2537533-A2 | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation | FIDIA FARMACEUTICI S.p.A. (IT) | 2012-12-26 | — | — | EP | disclosed |
| CN-102827177-A | Method for preparing henningsoline | NANJING ZELANG MEDICAL TECH CO | 2012-12-19 | — | — | CN | disclosed |
| EP-2520567-A2 | Nitrogen-containing heterocycle derivatives substituted with cyclic group | Shionogi & Co., Ltd. (JP) | 2012-11-07 | — | — | EP | disclosed |
| CN-102770979-A | Organic semiconductor material, field-effect transistor, and manufacturing method therefor | NIPPON KAYAKU KK | 2012-11-07 | — | — | CN | disclosed |
| US-20120264605-A1 | Multi-Functional Ionic Liquid Compositions for Overcoming Polymorphism and Imparting Improved Properties for Active Pharmaceutical, Biological, Nutritional, and Energetic Ingredients | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2012-10-18 | — | — | US | disclosed |
| CN-101405347-B | Organic compound, and semiconductor thin-film electrode, photoelectric conversion element, and photoelectrochemical solar cell using same | NAT INST OF ADVANCED IND SCIEN | 2012-09-12 | — | — | CN | disclosed |
| US-8232265-B2 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2012-07-31 | — | — | US | disclosed |
| CN-101479254-B | C-phenyl 1-thiosorbitol compounds | TAISHO PHARMACEUTICAL CO LTD | 2012-05-30 | — | — | CN | disclosed |
| CN-101103013-B | 1-thio-D-glucitol derivatives | TAISHO PHARMACEUTICAL CO LTD | 2012-05-23 | — | — | CN | disclosed |
| US-8168654-B2 | Quinuclidine derivatives binding to mucarinic M3 receptors | NOVARTIS AG (CH) | 2012-05-01 | — | — | US | disclosed |
| US-8124625-B2 | enhancing the expression of apoAI; prevention or therapy of dislipidemia | SHIONOGI & CO., LTD. (JP) | 2012-02-28 | — | — | US | disclosed |
| US-8115017-B2 | C-phenyl 1-thioglucitol compound | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2012-02-14 | — | — | US | disclosed |
| EP-2415745-A1 | DIPHENYLMETHANE COMPOUND | Ajinomoto Co., Inc. (JP) | 2012-02-08 | — | — | EP | disclosed |
| EP-2415744-A1 | FLUORENE COMPOUND | Ajinomoto Co., Inc. (JP) | 2012-02-08 | — | — | EP | disclosed |
| EP-2403027-A1 | Photoelectric conversion device and imaging device | Fujifilm Corporation (JP) | 2012-01-04 | — | — | EP | disclosed |
| US-20110309304-A1 | LUMINESCENT SILVER COMPLEX | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-22 | — | — | US | disclosed |
| CN-102272217-A | Surface functionalised nanoparticles | — | 2011-12-07 | — | — | CN | disclosed |
| US-8053445-B2 | Utilities of olefin derivatives | SHIONOGI & CO., LTD. (JP) | 2011-11-08 | — | — | US | disclosed |
| CN-102227437-A | Luminescent silver complexes | SUMITOMO CHEMICAL CO | 2011-10-26 | — | — | CN | disclosed |
| US-20110237529-A1 | Adenosine Analogs and Their Use | MICRODOSE THERAPEUTX, INC | 2011-09-29 | — | — | US | disclosed |
| EP-2367837-A2 | 1'-SUBSTITUTED RIBOSE 5'-POLYPHOSPHATE ANALOGS AND THEIR USE AS MODULATORS OF P2Y RECEPTOR ACTIVITY | MicroDose Therapeutx, Inc. (US) | 2011-09-28 | — | — | EP | disclosed |
| EP-1536440-B1 | ELECTRIC DOUBLE-LAYER CAPACITOR | NISSHINBO HOLDINGS INC (JP) | 2011-09-28 | — | — | EP | disclosed |
| US-8017792-B2 | 1-thio-D-glucitol derivatives | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2011-09-13 | — | — | US | disclosed |
| EP-1845095-B1 | 1-THIO-D-GLUCITOL DERIVATIVES | TAISHO PHARMACEUTICAL CO LTD (JP) | 2011-09-07 | — | — | EP | disclosed |
| EP-2360162-A1 | LUMINESCENT SILVER COMPLEXES | Sumitomo Chemical Company, Limited (JP) | 2011-08-24 | — | — | EP | disclosed |
| US-20110189265-A1 | THERAPEUTIC USE OF NEW PHARMACEUTICAL PREPARATIONS CONTAINING ANTITUMORAL DRUGS BOUND TO HYALURONIC ACID IN THE TREATMENT OF NEOPLASIAS | FIDIA FARMACEUTICI S.P.A. (IT) | 2011-08-04 | — | — | US | disclosed |
| US-20110172415-A1 | NITROGEN-CONTAINING HETEROCYCLE DERIVATIVES SUBSTITUTED WITH CYCLIC GROUP | SHIONOGI & CO., LTD. (JP) | 2011-07-14 | — | — | US | disclosed |
| US-20110171327-A1 | GUAVA PULP COMPOSITION | UNIVERSITI PUTRA MALAYSIA (MY) | 2011-07-14 | — | — | US | disclosed |
| US-7973172-B2 | Organic compound, semiconductor film electrode employing the organic compound, photoelectric conversion element employing the organic compound, and photoelectrochemical solar cell employing the organic compound | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2011-07-05 | — | — | US | disclosed |
| US-7964613-B2 | (S)-3-amino-1-(4-bromo-5-isoquinolinesulfonyl)pyrrolidine; inhibits phosphorylation of myosin regulatory light chain; for spinal canal stenosis, spinal cord injury, rheumatoid arthritis, multiple sclerosis; Rho kinase inhibitors | ASAHI KASEI PHARMA CORPORATION (JP) | 2011-06-21 | — | — | US | disclosed |
| US-7935706-B2 | Nitrogen-containing heterocycle derivatives substituted with cyclic group | SHIONOGI & CO., LTD. (JP) | 2011-05-03 | — | — | US | disclosed |
| US-20110098469-A1 | 1-THIO-D-GLUCITOL DERIVATIVES | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2011-04-28 | — | — | US | disclosed |
| CN-102014966-A | Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in the treatment of neoplasias | FIDIA FARMACEUTICI | 2011-04-13 | — | — | CN | disclosed |
| US-20110071145-A1 | Raf Modulators And Methods Of Use | EXELIXIS, INC. (US) | 2011-03-24 | — | — | US | disclosed |
| US-7910619-B2 | e.g. 2,3,4,6-tetra-O-benzyl-5-thio-D-glucono-1,5-lactone3,4-Dihydro-2H-pyran; inhibit the activity of sodium-dependent glucose cotransporter 2 (SGLT2) concerned with glucose reabsorption in the kidney; antidiabetic agent; diabetes-related disease, or diabetic complication | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2011-03-22 | — | — | US | disclosed |
| EP-2279006-A1 | THERAPEUTIC USE OF NEW PHARMACEUTICAL PREPARATIONS CONTAINING ANTITUMORAL DRUGS BOUND TO HYALURONIC ACID IN THE TREATMENT OF NEOPLASIAS | FIDIA FARMACEUTICI S.p.A. (IT) | 2011-02-02 | — | — | EP | disclosed |
| US-20100308311-A1 | PHOTOELECTRIC CONVERSION DEVICE AND IMAGING DEVICE | FUJIFILM CORPORATION (JP) | 2010-12-09 | — | — | US | disclosed |
| EP-2259358-A2 | Photoelectric conversion device and imaging device | Fujifilm Corporation (JP) | 2010-12-08 | — | — | EP | disclosed |
| CN-101908597-A | Photoelectric conversion device and imaging device | FUJIFILM CORP | 2010-12-08 | — | — | CN | disclosed |
| US-7846959-B2 | Raf modulators and methods of use | EXELIXIS, INC. (US) | 2010-12-07 | — | — | US | disclosed |
| US-20100286211-A1 | OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS | RANBAXY LABORATORIES LIMITED (IN) | 2010-11-11 | — | — | US | disclosed |
| US-20100249374-A1 | DIPHENYLMETHANE COMPOUND | AJINOMOTO CO., INC. (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20100240867-A1 | FLUORENE COMPOUND | AJINOMOTO CO. INC. (JP) | 2010-09-23 | — | — | US | disclosed |
| EP-1811999-B1 | QUINUCLIDINE DERIVATIVES AND THEIR USE AS MUSCARINIC M3 RECEPTOR ANTAGONISTS | NOVARTIS AG (CH) | 2010-09-15 | — | — | EP | disclosed |
| US-7785631-B2 | Solid dose delivery vehicle and methods of making same | QUADRANT DRUG DELIVERY LIMITED (GB) | 2010-08-31 | — | — | US | disclosed |
| US-7780991-B2 | Solid dose delivery vehicle and methods of making same | QUADRANT DRUG DELIVERY LIMITED (GB) | 2010-08-24 | — | — | US | disclosed |
| EP-2206499-A1 | QUINUCLIDINE DERIVATIVES AND THEIR USE AS MUSCARINIC M3 RECEPTOR ANTAGONISTS | Novartis AG (CH) | 2010-07-14 | — | — | EP | disclosed |
| US-20100173890-A1 | Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease | ASTRAZENECA AB (SE) | 2010-07-08 | — | — | US | disclosed |
| US-20100174095-A1 | ORGANIC COMPOUND, SEMICONDUCTOR FILM ELECTRODE EMPLOYING THE ORGANIC COMPOUND, PHOTOELECTRIC CONVERSION ELEMENT EMPLOYING THE ORGANIC COMPOUND, AND PHOTOELECTROCHEMICAL SOLAR CELL EMPLOYING THE ORGANIC COMPOUND | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2010-07-08 | — | — | US | disclosed |
| US-7744925-B2 | Solid dose delivery vehicle and methods of making same | QUADRANT DRUG DELIVERY LIMITED | 2010-06-29 | — | — | US | disclosed |
| US-7709238-B2 | Method for removing enzyme and method of base exchange or hydrolysis of phospholipid using the same | NAGASE CHEMTEX CORPORATION (JP) | 2010-05-04 | — | — | US | disclosed |
| US-20100105657-A1 | Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease | ASTRAZENECA AB (SE) | 2010-04-29 | — | — | US | disclosed |
| US-20100093789-A1 | SULFONAMIDE COMPOUND | ASAHI KASEI PHARMA CORPORATION (JP) | 2010-04-15 | — | — | US | disclosed |
| US-20100069460-A1 | 1-PHENYL 1-THIO-D-GLUCITOL DERIVATIVE | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20100041887-A1 | QUINUCLIDINE DERIVATIVES BINDING TO MUCARINIC M3 RECEPTORS | COLLINGWOOD STEPHEN PAUL | 2010-02-18 | — | — | US | disclosed |
| CN-101648877-A | Preparation method of quaternary ammonium carboxylate ion liquid with low halogen | NANJING UNIVERSITY OF TECHNOLOGY | 2010-02-17 | — | — | CN | disclosed |
| US-20100004465-A1 | C-PHENYL 1-THIOGLUCITOL COMPOUND | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2010-01-07 | — | — | US | disclosed |
| CN-101611023-A | The 1-phenyl 1-thio-D-glucitol derivative | TAISHO PHARMACEUTICAL CO LTD (JP) | 2009-12-23 | — | — | CN | disclosed |
| EP-2130828-A1 | SULFONAMIDE DERIVATIVE | Asahi Kasei Pharma Corporation (JP) | 2009-12-09 | — | — | EP | disclosed |
| US-7618984-B2 | Sulfonamide compound | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-11-17 | — | — | US | disclosed |
| WO-2009130564-A1 | THERAPEUTIC USE OF NEW PHARMACEUTICAL PREPARATIONS CONTAINING ANTITUMORAL DRUGS BOUND TO HYALURONIC ACID IN THE TREATMENT OF NEOPLASIAS | FIDIA FARMACEUTICI S.P.A. (IT) | 2009-10-29 | — | — | WO | disclosed |
| EP-2103607-A1 | 1-PHENYL 1-THIO-D-GLUCITOL DERIVATIVE | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2009-09-23 | — | — | EP | disclosed |
| EP-1937230-A4 | M3 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LTD (GB) | 2009-08-26 | — | — | EP | disclosed |
| EP-1631569-B1 | QUINUCLIDINE DERIVATIVES BINDING TO MUCARINIC M3 RECEPTORS | NOVARTIS AG (CH) | 2009-08-26 | — | — | EP | disclosed |
| US-7579469-B2 | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2009-08-25 | — | — | US | disclosed |
| US-20090203775-A1 | Novel compound and a novel microorganism for producing the novel compound | HAIYI BIOTECH PTE, LTD. | 2009-08-13 | — | — | US | disclosed |
| CN-101486661-A | Method for preparing tetraalkyl quaternary ammonium type amino acid ion liquid | NANJING UNIVERSITY OF TECHNOLOGY (CN) | 2009-07-22 | — | — | CN | disclosed |
| CN-101479254-A | C-phenyl 1-thiosorbitol compounds | TAISHO PHARMACEUTICAL CO LTD (JP) | 2009-07-08 | — | — | CN | disclosed |
| CN-101405347-A | Organic compound, and semiconductor thin-film electrode, photoelectric conversion element, and photoelectrochemical solar cell using same | NAT INST OF ADVANCED IND SCIEN (JP) | 2009-04-08 | — | — | CN | disclosed |
| EP-2036901-A1 | C-PHENYL 1-THIOGLUCITOL COMPOUND | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2009-03-18 | — | — | EP | disclosed |
| CN-100468587-C | Electric double-layer capacitor | NISSHIN SPINNING (JP) | 2009-03-11 | — | — | CN | disclosed |
| US-20090062261-A1 | NITROGEN-CONTAINING HETEROCYCLE DERIVATIVES SUBSTITUTED WITH CYCLIC GROUP | SHIONOGI & CO., LTD. (JP) | 2009-03-05 | — | — | US | disclosed |
| US-20090048223-A1 | Sulfonamide compound | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-02-19 | — | — | US | disclosed |
| US-20090036457-A1 | Utilities of olefin derivatives | YAMAMORI TERUO | 2009-02-05 | — | — | US | disclosed |
| CN-100445281-C | Quinuclidine derivatives binding to muscarinic M3 receptor | NOVARTIS AG (CH) | 2008-12-24 | — | — | CN | disclosed |
| US-7468375-B2 | Inhibitors of the HIV integrase enzyme | PFIZER INC. (US) | 2008-12-23 | — | — | US | disclosed |
| US-20080292703-A1 | Antitumoral Bioconjugates of Hyaluronic Acid or Its Derivatives Obtained by Indirect Chemical Conjugation, and Their Use in the Pharmaceutical Field | FIDIA FARMACEUTICI S.P.A. (IT) | 2008-11-27 | — | — | US | disclosed |
| CN-101304745-A | Diaryl ureas for the treatment of diabetic neuropathy | BAYER HEALTHCARE AG (DE) | 2008-11-12 | — | — | CN | disclosed |
| EP-1988077-A1 | NIROGENOUS HETEROCYCLIC DERIVATIVES SUBSTITUTED WITH CYCLIC GROUPS | SHIONOGI & CO., LTD. (JP) | 2008-11-05 | — | — | EP | disclosed |
| US-20080254995-A1 | NANOPORE ARRAYS AND SEQUENCING DEVICES AND METHODS THEREOF | DREXEL UNIVERSITY (US) | 2008-10-16 | — | — | US | disclosed |
| US-20080248543-A1 | Method For Removing Enzyme and Method of Base Exchange or Hydrolysis of Phospholipid Using the Same | Hayashibara Co., Ltd. (JP) | 2008-10-09 | — | — | US | disclosed |
| US-20080234315-A1 | M3 Muscarinic Acetylcholine Receptor Antagonists | GLAXO GROUP LIMITED (GB) | 2008-09-25 | — | — | US | disclosed |
| CN-101267840-A | Antitumor bioconjugates of hyaluronic acid or derivatives thereof obtained by indirect chemical conjugation | FIDIA FARMACEUTICI (IT) | 2008-09-17 | — | — | CN | disclosed |
| US-20080204972-A1 | Electric Double Layer Capacitor | NISSHINBO INDUSTRIES, INC. (JP) | 2008-08-28 | — | — | US | disclosed |
| US-20080193546-A1 | SOLID DOSE DELIVERY VEHICLE AND METHODS OF MAKING SAME | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 2008-08-14 | — | — | US | disclosed |
| CN-101229997-A | 2-methylene-5-substituted methylene cyclopentanone derivatives and uses thereof | UNIV SHENYANG PHARMACEUTICAL (CN) | 2008-07-30 | — | — | CN | disclosed |
| EP-1937230-A2 | M3 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2008-07-02 | — | — | EP | disclosed |
| CN-100396675-C | Prodrugs of proton pump inhibitors | PARTNERSHIP OF MICHAEL E GAST (US) | 2008-06-25 | — | — | CN | disclosed |
| EP-1932841-A1 | SULFONAMIDE COMPOUND | Asahi Kasei Pharma Corporation (JP) | 2008-06-18 | — | — | EP | disclosed |
| EP-1931760-A2 | MULTI-FUNCTIONAL IONIC LIQUID COMPOSITIONS | The University of Alabama (US) | 2008-06-18 | — | — | EP | disclosed |
| US-20080132563-A1 | 1-Thio-D-Glucitol Derivatives | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2008-06-05 | — | — | US | disclosed |
| WO-2008060632-A2 | ADENOSINE ANALOGS AND THEIR USE | EPIX DELAWARE, INC. (US) | 2008-05-22 | — | — | WO | disclosed |
| CN-101180055-A | Combination therapy comprising diaryl ureas for treating diseases | BAYER HEALTHCARE AG (DE) | 2008-05-14 | — | — | CN | disclosed |
| EP-1909843-A2 | ANTITUMORAL BIOCONJUGATES OF HYALURONIC ACID OR ITS DERIVATIVES OBTAINED BY INDIRECT CHEMICAL CONJUGATION, AND THEIR USE IN THE PHARMACEUTICAL FIELD | FIDIA FARMACEUTICI S.p.A. (IT) | 2008-04-16 | — | — | EP | disclosed |
| US-7354946-B2 | prominent growth inhibitory activity against tumor cells; cyclin dependent kinase inhibitors; colon cancer; N'-(3-t-butylisoindolino[3,2-b]oxazolidin-4-on-8-yl)-N-(4-(N-benzylpyrrolidin-3-yl)pyridin-2-yl)urea | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2008-04-08 | — | — | US | disclosed |
| US-7342769-B2 | Electric double-layer capacitor | NISSHINBO INDUSTRIES, INC. (JP) | 2008-03-11 | — | — | US | disclosed |
| US-20080009488-A1 | Raf Modulators and Methods of Use | EXELIXIS, INC. (US) | 2008-01-10 | — | — | US | disclosed |
| CN-101103013-A | 1-thio-D-glucitol derivatives | TAISHO PHARMACEUTICAL CO LTD (JP) | 2008-01-09 | — | — | CN | disclosed |
| EP-1845095-A1 | 1-THIO-D-GLUCITOL DERIVATIVES | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2007-10-17 | — | — | EP | disclosed |
| US-20070218531-A1 | Micro-Organism and a Method of Producing Paclitaxel by the Use of the Same | HAIYI BIOTECH PTE LTD (SG) | 2007-09-20 | — | — | US | disclosed |
| EP-1781773-A4 | A MICRO-ORGANISM AND A METHOD OF PRODUCING PACLITAXEL BY THE USE OF THE SAME | HAIYI BIOTECH PTE LTD (SG) | 2007-08-29 | — | — | EP | disclosed |
| US-20070179127-A1 | Sulfonamide compound | ASAHI KASEI PHARMA CORPORATION (JP) | 2007-08-02 | — | — | US | disclosed |
| EP-1811999-A1 | QUINUCLIDINE DERIVATIVES AND THEIR USE AS MUSCARINIC M3 RECEPTOR ANTAGONISTS | Novartis AG (CH) | 2007-08-01 | — | — | EP | disclosed |
| WO-2007014784-A9 | ANTITUMORAL BIOCONJUGATES OF HYALURONIC ACID OR ITS DERIVATIVES OBTAINED BY INDIRECT CHEMICAL CONJUGATION | FIDIA FARMACEUTICI (IT) | 2007-07-12 | — | — | WO | disclosed |
| EP-1781773-A1 | A MICRO-ORGANISM AND A METHOD OF PRODUCING PACLITAXEL BY THE USE OF THE SAME | Haiyi Biotech Pte Ltd. (SG) | 2007-05-09 | — | — | EP | disclosed |
| US-20070093462-A1 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA | 2007-04-26 | — | — | US | disclosed |
| WO-2007044693-A2 | MULTI-FUNCTIONAL IONIC LIQUID COMPOSITIONS | THE UNIVERSITY OF ALABAMA (US) | 2007-04-19 | — | — | WO | disclosed |
| US-7192939-B2 | Pestalotiopsis microsporia isolates and compounds derived therefrom | MONTANA STATE UNIVERSITY (US) | 2007-03-20 | — | — | US | disclosed |
| US-20070060563-A1 | Quinuclidine derivatives binding to mucarinic m3 receptors | NOVARTIS AG (CH) | 2007-03-15 | — | — | US | disclosed |
| EP-1756103-A2 | PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS HIV-INTEGRASE INHIBITORS | Pfizer, Inc. (US) | 2007-02-28 | — | — | EP | disclosed |
| CN-1916631-A | Enzyme linked immunoassay method for detecting content of oxygen pyrimidine in sulfanilamide-5 | UNIV YANGZHOU (CN) | 2007-02-21 | — | — | CN | disclosed |
| EP-1751124-A2 | RAF MODULATORS AND METHODS OF USE | Exelixis, Inc. (US) | 2007-02-14 | — | — | EP | disclosed |
| WO-2007014784-A2 | ANTITUMORAL BIOCONJUGATES OF HYALURONIC ACID OR ITS DERIVATIVES OBTAINED BY INDIRECT CHEMICAL CONJUGATION | FIDIA FARMACEUTICI S.P.A. (IT) | 2007-02-08 | — | — | WO | disclosed |
| WO-2007016650-A2 | M3 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2007-02-08 | — | — | WO | disclosed |
| US-20070027147-A1 | Biarylurea derivatives | MSD K.K. (JP) | 2007-02-01 | — | — | US | disclosed |
| EP-1739183-A1 | METHOD OF REMOVING ENZYME AND METHOD OF BASE EXCHANGE OR HYDROLYSIS OF PHOSPHOLIPID USING THE SAME | Nagase Chemtex Corporation (JP) | 2007-01-03 | — | — | EP | disclosed |
| EP-1715496-A1 | ELECTRIC DOUBLE LAYER CAPACITOR | Nisshinbo Industries, Inc. (JP) | 2006-10-25 | — | — | EP | disclosed |
| US-20060176646-A1 | Electric double-layer capacitor | NISSHINBO INDUSTRIES, INC. (JP) | 2006-08-10 | — | — | US | disclosed |
| CN-1784400-A | Quinuclidine derivatives binding to muscarinic M3 receptor | NOVARTIS AG (CH) | 2006-06-07 | — | — | CN | disclosed |
| US-7056495-B2 | Solid dose delivery vehicle and methods of making same | QUADRANT DRUG DELIVERY LTD. (GB) | 2006-06-06 | — | — | US | disclosed |
| WO-2006048225-A1 | QUINUCLIDINE DERIVATIVES AND THEIR USE AS MUSCARINIC M3 RECEPTOR ANTAGONISTS | NOVARTIS AG (CH) | 2006-05-11 | — | — | WO | disclosed |
| EP-1631569-A2 | QUINUCLIDINE DERIVATIVES BINDING TO MUCARINIC M3 RECEPTORS | Novartis AG (CH) | 2006-03-08 | — | — | EP | disclosed |
| EP-1625130-A2 | HIV INTEGRASE INHIBITORS | Tibotec Pharmaceuticals Ltd. (IE) | 2006-02-15 | — | — | EP | disclosed |
| CN-1735599-A | 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands | BOEHRINGER INGELHEIM PHARMA (US) | 2006-02-15 | — | — | CN | disclosed |
| WO-2006009518-A1 | A MICRO-ORGANISM AND A METHOD OF PRODUCING PACLITAXEL BY THE USE OF THE SAME | HAIYI BIOTECH PTE LTD (SG) | 2006-01-26 | — | — | WO | disclosed |
| US-20050277662-A1 | Inhibitors of the HIV integrase enzyme | AGOURON PHARMACEUTICALS, INC | 2005-12-15 | — | — | US | disclosed |
| US-20050276846-A1 | Solid dose delivery vehicle and methods of making same | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 2005-12-15 | — | — | US | disclosed |
| US-20050276759-A1 | Solid dose delivery vehicle and methods of making same | QUADRANT HEALTHCARE (UK) LIMITED (GB) | 2005-12-15 | — | — | US | disclosed |
| US-20050276845-A1 | Solid dose delivery vehicle and methods of making same | QUADRANT HEALTHCARE (UK) LIMITED (GB) | 2005-12-15 | — | — | US | disclosed |
| EP-1199306-B1 | BIARYLUREA DERIVATIVES | BANYU PHARMA CO LTD (JP) | 2005-12-07 | — | — | EP | disclosed |
| WO-2005112932-A2 | RAF MODULATORS AND METHODS OF USE | EXELIXIS, INC. (US) | 2005-12-01 | — | — | WO | disclosed |
| US-6965041-B1 | N-acylphosphoramidites and their use in oligonucleotide synthesis | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2005-11-15 | — | — | US | disclosed |
| WO-2005103003-A2 | PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS HIV-INTEGRASE INHIBITORS | PFIZER INC. (US) | 2005-11-03 | — | — | WO | disclosed |
| US-6958333-B1 | Biarylurea derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2005-10-25 | — | — | US | disclosed |
| EP-1583745-A1 | 1-PROPANOL AND 1-PROPYLAMINE DERIVATIVES AND THEIR USE AS GLUCOCORTICOID LIGANDS | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 2005-10-12 | — | — | EP | disclosed |
| CN-1679126-A | Electric double-layer capacitor | NISSHIN SPINNING (JP) | 2005-10-05 | — | — | CN | disclosed |
| WO-2005082860-A1 | TETRACYCLINES AND THEIR USE AS CALPAIN INHIBITORS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2005-09-09 | — | — | WO | disclosed |
| EP-1557168-A2 | Biarylurea Derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2005-07-27 | — | — | EP | disclosed |
| US-20050159599-A1 | Cyclic compound, process for producing the same, and pest control agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-21 | — | — | US | disclosed |
| US-20050136285-A1 | Multi-layered device and method for making the same | GENERAL ELECTRIC COMPANY | 2005-06-23 | — | — | US | disclosed |
| EP-1536440-A1 | ELECTRIC DOUBLE-LAYER CAPACITOR | Nisshinbo Industries, Inc. (JP) | 2005-06-01 | — | — | EP | disclosed |
| US-6893657-B2 | Solid dose delivery vehicle and methods of making same | QUADRANT DRUG DELIVERY LTD. (GB) | 2005-05-17 | — | — | US | disclosed |
| US-6872832-B2 | Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-03-29 | — | — | US | disclosed |
| EP-1516615-A2 | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same | Quadrant Drug Delivery Limited (GB) | 2005-03-23 | — | — | EP | disclosed |
| US-6869971-B1 | UCS1025 derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2005-03-22 | — | — | US | disclosed |
| US-20040242615-A1 | Utilities of olefin derivatives | SHIONOGI & CO., LTD. (JP) | 2004-12-02 | — | — | US | disclosed |
| US-20040229900-A1 | Bispidine compounds useful in the treatment of cardiac arrythmias | ASTRAZENECA AB (SE) | 2004-11-18 | — | — | US | disclosed |
| WO-2004096800-A2 | QUINUCLIDINE DERIVATIVES BINDING TO MUCARINIC M3 RECEPTORS | NOVARTIS AG (CH) | 2004-11-11 | — | — | WO | disclosed |
| WO-2004096807-A2 | HIV INTEGRASE INHIBITORS | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2004-11-11 | — | — | WO | disclosed |
| US-20040219206-A1 | Solid dose delivery vehicle and methods of making same | ROSER BRUCE J (GB) | 2004-11-04 | — | — | US | disclosed |
| US-6811792-B2 | SOLID SOLUTION OF BIOACTIVE MATERIAL IN GLASS; BOMBARDMENT ADMINISTERING | QUADRANT DRUG DELIVERY LTD. (GB) | 2004-11-02 | — | — | US | disclosed |
| EP-1104761-B1 | FLUORESCENT LABELLING REAGENTS | DAIICHI PURE CHEMICALS CO LTD (JP) | 2004-10-13 | — | — | EP | disclosed |
| US-20040162321-A1 | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2004-08-19 | — | — | US | disclosed |
| EP-0888389-B1 | PHOTOACTIVATABLE CHAIN TRANSFER AGENTS | SURMODICS INC (US) | 2004-08-04 | — | — | EP | disclosed |
| WO-2004063163-A1 | 1-PROPANOL AND 1-PROPYLAMINE DERIVATIVES AND THEIR USE AS GLUCOCORTICOID LIGANDS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2004-07-29 | — | — | WO | disclosed |
| US-6762298-B2 | DEPROTECTING AN OLIGONUCLEOTIDE BY HEATING IN A FLUID, WHERE THE PHOSPHORUS ATOM IS O-PROTECTED WITH A THERMOLABILE GROUP SUCH AS (PYRROLIDIN-1-ONE-1-YL)ALKYL; SYNTHESIS OF OLIGONUCLEOTIDES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2004-07-13 | — | — | US | disclosed |
| US-6756376-B1 | PREVENTING FATTY ACID RELEASE | SHIONOGI & CO., LTD. (JP) | 2004-06-29 | — | — | US | disclosed |
| WO-2003064617-A9 | PESTALOTIOPSIS MICROSPORIA ISOLATES AND COMPOUNDS DERIVED THEREFROM | UNIV MONTANA STATE (US) | 2004-06-24 | — | — | WO | disclosed |
| US-20040106635-A1 | having small-conductance potassium channel (SK) blocking activity | TANABE SEIYAKU CO., LTD. (JP) | 2004-06-03 | — | — | US | disclosed |
| EP-0924248-B1 | Stabilization of polycarbonate/ABS blends with mixtures of hindered amines and UV absorbers | CIBA SC HOLDING AG (CH) | 2004-04-28 | — | — | EP | disclosed |
| US-20040052825-A1 | Solid dose delivery vehicle and methods of making same | QUADRANT DRUG DELIVERY LIMITED (GB) | 2004-03-18 | — | — | US | disclosed |
| US-6703385-B1 | PYRIDOINDOLE DERIVATIVES; SECRETORY PHOSPHOLIPASE INHIBITORS; RESPIRATORY SYSTEM, GASTROINTESTINAL AND CARDIOVASCULAR DISORDERS | SHIONOGI & CO., LTD. (JP) | 2004-03-09 | — | — | US | disclosed |
| US-20040009573-A1 | A biologically pure culture of Pestalotiopsis microspora strain 12-30 characterized by possessing antioxidant and antifungal activities in culture media, and containing 1,5,7 trisubstituted 1,3-dihydroisobenzofurans | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-01-15 | — | — | US | disclosed |
| US-6673781-B1 | INHIBIT SECRETORY PHOSPHOLIPASE A2-MEDIATED FATTY ACID RELEASE; TREATING ADULT RESPIRATORY SYNDROME, PANCREATITIS, BRONCHIAL ASTHMA, ALLERGIC RHINITIS, CHRONIC RHEUMATISM, ARTERIOSCLEROSIS, CEREBRAL INFARCTION AND PSORIASIS | SHIONOGI & CO., LTD. (JP) | 2004-01-06 | — | — | US | disclosed |
| US-6638997-B2 | Used for stabilizing polyolefin and automotive coating formulation against the deleterious effects of oxidative, thermal and actinic radiation | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-10-28 | — | — | US | disclosed |
| US-20030147961-A1 | Solid dose delivery vehicle and methods of making same | QUADRANT DRUG DELIVERY LIMITED (GB) | 2003-08-07 | — | — | US | disclosed |
| WO-2003064617-A2 | PESTALOTIOPSIS MICROSPORIA ISOLATES AND COMPOUNDS DERIVED THEREFROM | MONTANA STATE UNIVERSITY (US) | 2003-08-07 | — | — | WO | disclosed |
| US-6586006-B2 | Vitreous vehicle loaded with guest substance such as drugs, enzymes, vaccines; vehicle allows guest substance to be dried and stored without loss of activity | ELAN DRUG DELIVERY LIMITED (GB) | 2003-07-01 | — | — | US | disclosed |
| US-6586507-B2 | For stabilizing polyolefins, especially thermoplastic polyolefins, against the deleterious effects of oxidative, thermal and actinic radiation, also for stabilizing acid catalyzed and ambient cured coatings systems | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-07-01 | — | — | US | disclosed |
| US-20030120077-A1 | Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES PETER (US) | 2003-06-26 | — | — | US | disclosed |
| US-6565871-B2 | For administration of a bioactive material to subcutaneous and intradermal tissue | ELAN DRUG DELIVERY LTD. (GB) | 2003-05-20 | — | — | US | disclosed |
| EP-0819718-B1 | Tetraphenol polycarbonate branching agents | GEN ELECTRIC (US) | 2003-05-14 | — | — | EP | disclosed |
| US-6559167-B1 | Prodrugs of the pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs have a hydrolyzable arylsulfonyl or heteroarylsulfonyl group attached to the benzimidazole nitrogen. The prodrugs of the invention hydrolyze under | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-05-06 | — | — | US | disclosed |
| CN-1107059-C | Azole deriv. | YAMANOUCHI PHARMA CO LTD (JP) | 2003-04-30 | — | — | CN | disclosed |
| US-6555559-B1 | Prostaglandin I2 (PGI2); use as an anti-Helicobacter agent, a platelet function potentiating agent or a cervical ripening agent; side effect reduction | TORAY INDUSTRIES, INC. (JP) | 2003-04-29 | — | — | US | disclosed |
| US-20030054040-A1 | Solid solution of bioactive material in glass; bombardment administering | QUADRANT DRUG DELIVERY LIMITED (GB) | 2003-03-20 | — | — | US | disclosed |
| US-6514732-B1 | Acetylation of 10-deacetylbaccatin using acetyl transferase with acetyl coA; 10-hydroxytaxa-O-acetyltransferase; Used in preparation of taxol. | INDENA S.P.A. (IT) | 2003-02-04 | — | — | US | disclosed |
| EP-1105387-B1 | PRODRUGS OF PROTON PUMP INHIBITORS | WINSTON PHARMATEUTICALS LLC (US) | 2003-01-29 | — | — | EP | disclosed |
| CN-1097055-C | Taxane derivatives preparation thereof and formulation containing them | INDENA SPA (IT) | 2002-12-25 | — | — | CN | disclosed |
| US-6472389-B1 | Pyrrolo[1,2-b] pyridazine derivatives having sPLA2 inhibitory effect | SHIONOGI & CO., LTD. (JP) | 2002-10-29 | — | — | US | disclosed |
| WO-2002081491-A2 | NEW GENISTEIN DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | INSTYTUT FARMACEUTYCZNY (PL) | 2002-10-17 | — | — | WO | disclosed |
| US-6465625-B1 | TAXOL DERIVATIVES ARE THE PRODUCT OF HIGHLY SPECIFIC BIOCATALYTIC REACTIONS | ALBANY MOLECULAR RESEARCH, INC. | 2002-10-15 | — | — | US | disclosed |
| WO-2002079219-A2 | ANTI-PROLIFERATIVE 6-O-ACYL-BETA-D-GLUCOSYL-BETA-SITOSTEROL COMPOUNDS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2002-10-10 | — | — | WO | disclosed |
| US-6423199-B1 | CHLORINE SUBSTITUTED POLYNUCLEAR COBALT DICARBOLLIDE | BRITISH NUCLEAR FUELS PLC (GB) | 2002-07-23 | — | — | US | disclosed |
| US-6420562-B2 | OXIDATION, HEAT AND RADIATION RESISTANCE | CIBA SPECIALITY CHEMICALS CORPORATION | 2002-07-16 | — | — | US | disclosed |
| US-6420463-B1 | HEAT RESISTANCE, OXIDATION RESISTANCE OR PHOTOSTABILITY | CIBA SPECIALTY CHEMICALS CORP. | 2002-07-16 | — | — | US | disclosed |
| EP-0713533-B1 | BIOCATALYTIC METHODS FOR SYNTHESIZING AND IDENTIFYING BIOLOGICALLY ACTIVE COMPOUNDS | ALBANY MOLECULAR RES INC (US) | 2002-07-10 | — | — | EP | disclosed |
| EP-1212096-A2 | DRUG CONJUGATES AND METHODS OF DESIGNING THE SAME | Brenner, Sydney (US) | 2002-06-12 | — | — | EP | disclosed |
| US-6403625-B1 | 2(7-(1,3-DIHYDRO-1,1-DIMETHYL-3-ETHYLBENZ(E)INDOLIN-2-YLIDENE) -1,3,5-HEPTATRIENYL)-1,1-DIMETHYL-3-((6-((1,3-THIAZOLIDINE-2-T HION)-1-YL)-6-OXO)HEXYL)-1H-BENZ(E)INDOLIUM CHLORIDE; STAINS PROTEINS FOR CANCER IDENTIFICATION | DAIICHI PURE CHEMICALS CO., LTD. (JP) | 2002-06-11 | — | — | US | disclosed |
| US-6403681-B2 | STABILIZER FOR PLASTICS | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-06-11 | — | — | US | disclosed |
| EP-0786457-B1 | AZOLE DERIVATIVES | YAMANOUCHI PHARMA CO LTD (JP) | 2002-05-29 | — | — | EP | disclosed |
| US-6392041-B1 | OXIDATION, HEAT AND RADIATION RESISTANCE | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-05-21 | — | — | US | disclosed |
| US-6391949-B2 | FOR AUTOMOBILE FINISHES; HEAT, OXIDATION, RADIATION RESISTANCE | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-05-21 | — | — | US | disclosed |
| US-20020058735-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES PETER (US) | 2002-05-16 | — | — | US | disclosed |
| US-6388072-B2 | TETRAALKYL SUBSTITUTED PIPERIDINE SUBSTITUTED ON THE N-ATOM WITH O-E-OH GROUP (E= ALKYLENE OR PHENYLENE OR CYCLOALIPHATIC DERIVATIVES) ARE USED FOR STABILIZING POLYOLEFINS AND AUTOMOTIVE COATING AGAINST HEAT, OXIDATION | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-05-14 | — | — | US | disclosed |
| US-6380389-B2 | FOR POLYOLEFINS AND AUTOMOTIVE COATINGS; LIGHT, HEAT, OXIDATION RESISTANCE | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-04-30 | — | — | US | disclosed |
| EP-1199306-A1 | BIARYLUREA DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2002-04-24 | — | — | EP | disclosed |
| US-6376584-B1 | OXIDATION RESISTANCE, HEAT RESISTANCE, PHOTOSTABILITY | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-04-23 | — | — | US | disclosed |
| EP-0755928-B1 | 5-AMINOFLAVONE DERIVATIVES | KYOWA HAKKO KOGYO KK (JP) | 2002-04-10 | — | — | EP | disclosed |
| US-20020040145-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2002-04-04 | — | — | US | disclosed |
| US-20020012687-A1 | Solid dose delivery vehicle and methods of making same | QDOSE LIMITED (GB) | 2002-01-31 | — | — | US | disclosed |
| US-6331310-B1 | THERAPEUTIC AGENT AND STABILIZING POLYOL, PREFERABLY THE DISSACCHARIDE TREHALOSE | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 2001-12-18 | — | — | US | disclosed |
| US-6329193-B1 | A PURE CULTURE OF A FUNGUS, TAXOMYCES, PRODUCING TAXOL OR TAXANE IN THE CULTURE MEDIUM; THERAPY FOR CANCER AND LEUKEMIA | THE RESEARCH AND DEVELOPMENT INSTITUTE AT MONTANA STATE UNIVERSITY | 2001-12-11 | — | — | US | disclosed |
| US-20010044529-A1 | Thermolabile phosphorus protecting groups, associated intermediates and methods of use | GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2001-11-22 | — | — | US | disclosed |
| US-20010038858-A1 | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same | QUADRANT DRUG DELIVERY LIMITED (GB) | 2001-11-08 | — | — | US | disclosed |
| US-20010034449-A1 | Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-10-25 | — | — | US | disclosed |
| US-20010031872-A1 | Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-10-18 | — | — | US | disclosed |
| EP-1138319-A2 | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 2001-10-04 | — | — | EP | disclosed |
| EP-1138337-A2 | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 2001-10-04 | — | — | EP | disclosed |
| US-6290991-B1 | POLYOL AND A BIOACTIVE AGENT WHEREIN SAID POLYOL IS AMORPHOUS OR NON-CRYSTALLINE AND STABILIZES SAID BIOACTIVE AGENT, AND WHEREIN SAID THERAPEUTIC COMPOSITION IS A POWDER SUITABLE FOR ADMINISTRATION BY INHALATION | QUANDRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 2001-09-18 | — | — | US | disclosed |
| CN-1312806-A | Prodrugs of proton pump inhibitors | PARTNERSHIP OF MICHAEL E GAST (US) | 2001-09-12 | — | — | CN | disclosed |
| US-20010020099-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-09-06 | — | — | US | disclosed |
| US-20010018520-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-08-30 | — | — | US | disclosed |
| US-20010016658-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-08-23 | — | — | US | disclosed |
| US-6271377-B1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-08-07 | — | — | US | disclosed |
| CN-1302300-A | Pyrrolo [1, 2-b]Pyridazine sPLA2Inhibitors | SHIONOGI & CO (JP) | 2001-07-04 | — | — | CN | disclosed |
| EP-1105387-A1 | PRODRUGS OF PROTON PUMP INHIBITORS | Partnership of Michael E. Garst, George Sachs and Jai Moo Shin (US) | 2001-06-13 | — | — | EP | disclosed |
| EP-1104761-A1 | FLUORESCENT LABELLING REAGENTS | DAIICHI PURE CHEMICALS CO., LTD. (JP) | 2001-06-06 | — | — | EP | disclosed |
| EP-0808315-B1 | CARBAPENEM-3-CARBOXYLIC ACID ESTER DERIVATIVES | WYETH LEDERLE JAPAN LTD (JP) | 2001-04-04 | — | — | EP | disclosed |
| WO-2001013958-A2 | DRUG CONJUGATES AND METHODS OF DESIGNING THE SAME | BRENNER SYDNEY (US) | 2001-03-01 | — | — | WO | disclosed |
| US-6136961-A | TAXOL-2'-ADIPATE DERIVATIVES WITH IMPROVED WATER SOLUBILITY, BERGENIN DERIVATIVES, AND ERYTHROMYCIN DERIVATIVES OF GIVEN FORMULAS; FREE ACID OR SUGAR-CONTAINING DERIVATIVES THEREOF | ENZYMED, INC. (US) | 2000-10-24 | — | — | US | disclosed |
| US-6093734-A | PYRIDYL METHYL SULFINYL BENZIMIDAZOLE TYPE PROTON PUMP INHIBITOR DRUGS HAVING A HYDROLYZABLE SULFINYL OR ARYLSULFONYL GROUP ATTACHED TO THE BENZIMIDAZOLE NITROGEN; GASTROINTESTINAL DISORDERS | PARTNERSHIP OF MICHAEL E. GARST, GEORGE SACHS, AND JAI MOO SHIN (US) | 2000-07-25 | — | — | US | disclosed |
| WO-2000009498-A1 | PRODRUGS OF PROTON PUMP INHIBITORS | PARTNERSHIP OF MICHAEL E. GARST, GEORGE SACHS AND JAI MOO SHIN (US) | 2000-02-24 | — | — | WO | disclosed |
| EP-0978280-A1 | 2-AZABICYCLO COMPOUNDS | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2000-02-09 | — | — | EP | disclosed |
| US-6013493-A | MAKING A TAXANE; EXPOSING A MICROBE WHICH MAKES TAXANE TO CONDITIONS WHICH ALLOW IT TO MAKE TAXANE IN CULTURE, ALLOW MICROORGANISM TO PROPAGATE, ISOLATE OR CONCENTRATE TAXANE; ANTICARCINOGENIC AGENTS | THE RESEARCH AND DEVELOPMENT INSTITUTE AT MONTANA STATE UNIVERSITY (US) | 2000-01-11 | — | — | US | disclosed |
| EP-0968209-A1 | THIAZOLE BENZENESULFONAMIDES AS $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY | Merck & Co., Inc. (US) | 2000-01-05 | — | — | EP | disclosed |
| US-5990208-A | BLEND OF POLYCARBONATE AND POLYESTERS, STYRENIC COPOLYMERS, RUBBERS OR VINYL CHLORIDE CO- OR HOMOPOLYMERS, 1,3,5-TRIS(N-CYCLOHEXYL-N-(2-(3,3,4,5,5-PENTAMETHYLPIPERAZINE-2-ON-1-YL)-ET HYL)AMINO-S-TRIAZINE AND UV ABSORBER; AUTOMOBILES | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-11-23 | — | — | US | disclosed |
| US-5981564-A | GLUTARYLPACLITAXEL, GLUTARYLPACLITAXEL 6-AMINOHEXANOL GLUCURONIDE AND AMINO ACID DERIVATIVES OF GLUTARYLPACLITAXEL, ALL OF WHICH POSSESS THE CYTOTOXICITY ACTIVITY OF THE PARENT COMPOUND, PACLITAXEL; ANTICANCER AGENTS | UNIVERSITE LAVAL (CA) | 1999-11-09 | — | — | US | disclosed |
| US-5981559-A | USEFUL IN PREVENTING OR TREATING ALLERGIC DISEASES, ISCHEMIC HEART DISEASES OR ISCHEMIC BRAIN DISEASES | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1999-11-09 | — | — | US | disclosed |
| EP-0871620-A4 | BIOCATALYTIC METHODS FOR SYNTHESIZING AND IDENTIFYING BIOLOGICALLY ACTIVE COMPOUNDS | ENZYMED INC (US) | 1999-10-27 | — | — | EP | disclosed |
| US-5965434-A | COMPOUNDS CONTAIN CATIONIC GROUPS WHOSE POSITIVE CHARGE INCREASES WITH DECREASING PH; CATIONIC LIPOSOMES FUSE AT PH'S IN THE LOW END OF THE PHYSIOLOGIC RANGE; USE IN DRUG DELIVERY SYSTEMS; EFFICIENCY, LESS TOXICITY | FUGENT, LLC | 1999-10-12 | — | — | US | disclosed |
| US-5958741-A | PROCESS FOR PRODUCING TAXOL, USING A TAXOL PRODUCING MICROBE FOLLOWED BY SEPARATION OF TAXOL FROM THE GROWTH MEDIUM AND/OR MICROBE; CULTURING FUNGAL TISSUE FRAGMENTS FROM A TREE OF THE GENUS TAXUS | THE RESEARCH AND DEVELOPMENT INSTITUTE AT MONTANA STATE UNIVERSITY (US) | 1999-09-28 | — | — | US | disclosed |
| US-5942555-A | Photoactivatable chain transfer agents and semi-telechelic photoactivatable polymers prepared therefrom | SURMODICS, INC. (US) | 1999-08-24 | — | — | US | disclosed |
| EP-0760368-B1 | PYRIMIDINE DERIVATIVES | NISSHIN FLOUR MILLING CO (JP) | 1999-07-28 | — | — | EP | disclosed |
| EP-0924248-A1 | Stabilization of polycarbonate/ABS blends with mixtures of hindered amines and UV absorbers | Ciba SC Holding AG (CH) | 1999-06-23 | — | — | EP | disclosed |
| CN-1218475-A | Taxane derivatives, process for their preparation and formulations containing them | INDENA SPA (IT) | 1999-06-02 | — | — | CN | disclosed |
| US-5900493-A | Triterpene derivatives of azadirachtin having insect antifeedant and growth inhibitory activity | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 1999-05-04 | — | — | US | disclosed |
| CN-1042732-C | Antimicrobial agent for animals | DAIICHI SEIYAKU CO (JP) | 1999-03-31 | — | — | CN | disclosed |
| US-5886172-A | ORAL PRODRUG READILY ABSORPED IN THE DIGESTIVE TRACT AND HYDROLYZED; BIOAVAILABIITY; STRONG ANTIBACTERIAL ACTIVITY ESPECIALLY AGAINST STAPHYLOCOCCUS; STREPTOCOCCUS, KLEBSIELLA AND PROTEUS | LEDERLE (JAPAN) LTD. (JP) | 1999-03-23 | — | — | US | disclosed |
| US-5863992-A | BISPHENOL A FOR POLYCARBONATES | GENERAL ELECTRIC COMPANY (US) | 1999-01-26 | — | — | US | disclosed |
| US-5861302-A | GENUS TAXUS FOR PRODUCTION OF TAXOL OR TAXANE FROM CULTURE | THE RESEARCH AND DEVELOPMENT INSTITUTE AT MONTANA STATE UNIVERSITY (US) | 1999-01-19 | — | — | US | disclosed |
| EP-0638566-B1 | 5-Aminoflavone derivatives, their preparation and their use as antibacterial, anti-estrogenic and/or antitumor agent | KYOWA HAKKO KOGYO KK (JP) | 1999-01-07 | — | — | EP | disclosed |
| EP-0574135-B1 | Process for producing peptide derivatives and salts thereof | JAPAN ENERGY CORP (JP) | 1998-11-18 | — | — | EP | disclosed |
| EP-0871620-A1 | BIOCATALYTIC METHODS FOR SYNTHESIZING AND IDENTIFYING BIOLOGICALLY ACTIVE COMPOUNDS | ENZYMED, Inc. (US) | 1998-10-21 | — | — | EP | disclosed |
| WO-1998032753-A1 | THIAZOLE BENZENESULFONAMIDES AS β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY | MERCK & CO., INC. (US) | 1998-07-30 | — | — | WO | disclosed |
| US-5756773-A | INSECTICIDES AND ANTIGROWTH AGENTS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 1998-05-26 | — | — | US | disclosed |
| US-5736550-A | TREATMENT OF GASTROINTESTINAL TRACT DISORDERS | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1998-04-07 | — | — | US | disclosed |
| CN-1172822-A | Tetraphenols and their use as polycarbonate branching agents | GEN ELECTRIC (US) | 1998-02-11 | — | — | CN | disclosed |
| EP-0819718-A1 | Tetraphenol polycarbonate branching agents | GENERAL ELECTRIC COMPANY (US) | 1998-01-21 | — | — | EP | disclosed |
| EP-0817773-A2 | PYRIMIDINE COMPOUNDS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 1998-01-14 | — | — | EP | disclosed |
| EP-0808315-A1 | CARBAPENEM-3-CARBOXYLIC ACID ESTER DERIVATIVES | LEDERLE (JAPAN), Ltd. (JP) | 1997-11-26 | — | — | EP | disclosed |
| CN-1160397-A | Azole deriv. | YAMANOUCHI PHARMA CO LTD (JP) | 1997-09-24 | — | — | CN | disclosed |
| EP-0556720-B1 | 5-Aminoflavone derivatives | KYOWA HAKKO KOGYO KK (JP) | 1997-09-17 | — | — | EP | disclosed |
| US-5663374-A | ANTIGROWTH AGENTS FOR INSECTS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 1997-09-02 | — | — | US | disclosed |
| EP-0786457-A1 | AZOLE DERIVATIVE | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1997-07-30 | — | — | EP | disclosed |
| US-5644028-A | Process for producing peptide derivatives and salts therefor | JAPAN ENERGY CORPORATION (JP) | 1997-07-01 | — | — | US | disclosed |
| WO-1997021712-A1 | CARBAPENEM-3-CARBOXYLIC ACID ESTER DERIVATIVES | LEDERLE (JAPAN), LTD. (JP) | 1997-06-19 | — | — | WO | disclosed |
| US-5635487-A | DRUG DELIVERY | BUDKER, TATYANA | 1997-06-03 | — | — | US | disclosed |
| EP-0773781-A1 | SOLID DELIVERY SYSTEMS FOR CONTROLLED RELEASE OF MOLECULES INCORPORATED THEREIN AND METHODS OF MAKING SAME | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 1997-05-21 | — | — | EP | disclosed |
| WO-1997010233-A1 | BIOCATALYTIC METHODS FOR SYNTHESIZING AND IDENTIFYING BIOLOGICALLY ACTIVE COMPOUNDS | ENZYMED, INC. (US) | 1997-03-20 | — | — | WO | disclosed |
| EP-0760368-A1 | NOVEL PYRIMIDINE DERIVATIVE | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1997-03-05 | — | — | EP | disclosed |
| US-5602261-A | INSECTICIDES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 1997-02-11 | — | — | US | disclosed |
| EP-0755928-A1 | 5-AMINOFLAVONE DERIVATIVES | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1997-01-29 | — | — | EP | disclosed |
| EP-0227241-B1 | Medicinal indole and indazole keto sulphone derivatives | ZENECA INC (US) | 1996-09-11 | — | — | EP | disclosed |
| US-5539112-A | 5-aminoflavone derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1996-07-23 | — | — | US | disclosed |
| EP-0713533-A1 | BIOCATALYTIC METHODS FOR SYNTHESIZING AND IDENTIFYING BIOLOGICALLY ACTIVE COMPOUNDS | ENZYMED, Inc. (US) | 1996-05-29 | — | — | EP | disclosed |
| WO-1996005511-A1 | BIOCATALYTIC METHODS FOR SYNTHESIZING AND IDENTIFYING BIOLOGICALLY ACTIVE COMPOUNDS | ENZYMED, INC. (US) | 1996-02-22 | — | — | WO | disclosed |
| WO-1996003978-A1 | SOLID DELIVERY SYSTEMS FOR CONTROLLED RELEASE OF MOLECULES INCORPORATED THEREIN AND METHODS OF MAKING SAME | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 1996-02-15 | — | — | WO | disclosed |
| EP-0465581-B1 | ERYTHROMYCIN DERIVATIVES | ABBOTT LAB (US) | 1995-10-04 | — | — | EP | disclosed |
| US-5424164-A | Image forming method | FUJI PHOTO FILM CO., LTD (JP) | 1995-06-13 | — | — | US | disclosed |
| US-5395951-A | Triterpene derivatives of azadirachtin having insect antifeedant and growth inhibitory activity and a process for extracting such compounds from the neem plant | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 1995-03-07 | — | — | US | disclosed |
| WO-1995005475-A1 | BIOCATALYTIC METHODS FOR SYNTHESIZING AND IDENTIFYING BIOLOGICALLY ACTIVE COMPOUNDS | ENZYMED, INC. (US) | 1995-02-23 | — | — | WO | disclosed |
| EP-0638566-A1 | 5-Aminoflavone derivatives, their preparation and their use as antibacterial, anti-estrogenic and/or antitumor agent | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1995-02-15 | — | — | EP | disclosed |
| WO-1995002604-A1 | A3 ADENOSINE RECEPTOR AGONISTS | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-01-26 | — | — | WO | disclosed |
| US-5304373-A | BMY-46164 derived via the fermentation of strain of actinomadura | BRISTOL-MYERS SQUIBB CO. (US) | 1994-04-19 | — | — | US | disclosed |
| EP-0583945-A2 | Assay for 1,25 Dihydroxy Vitamin D | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1994-02-23 | — | — | EP | disclosed |
| US-5288709-A | Erythromycin derivatives | ABBOTT LABORATORIES (US) | 1994-02-22 | — | — | US | disclosed |
| US-5281417-A | Administering compound BMY46164 | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-01-25 | — | — | US | disclosed |
| EP-0574135-A1 | Process for producing peptide derivatives and salts thereof | JAPAN ENERGY CORPORATION (JP) | 1993-12-15 | — | — | EP | disclosed |
| US-5252570-A | Amidino and guanidino derivatives | B.I. ITALIA (IT) | 1993-10-12 | — | — | US | disclosed |
| EP-0560232-A1 | Novel 7-aminolabdanes, a process for their preparation and their use as pharmaceutical agents | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-09-15 | — | — | EP | disclosed |
| EP-0556720-A1 | 5-Aminoflavone derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1993-08-25 | — | — | EP | disclosed |
| CN-1071950-A | New antitumor antibiotics | BRISTOL MYERS SQUIBB CO (US) | 1993-05-12 | — | — | CN | disclosed |
| US-5208148-A | Leuco xanthene dyes | MOLECULAR PROBES, INC. (US) | 1993-05-04 | — | — | US | disclosed |
| EP-0538781-A2 | Antitumor antibiotic from actinomadura | Bristol-Myers Squibb Company (US) | 1993-04-28 | — | — | EP | disclosed |
| US-5175160-A | Nontoxic, broad spectrum | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1992-12-29 | — | — | US | disclosed |
| US-5140031-A | Pyranyl cyanoguanidine derivatives | E. R. SQUIBB & SONS, INC. (US) | 1992-08-18 | — | — | US | disclosed |
| EP-0465581-A4 | ERYTHROMYCIN DERIVATIVES | — | 1992-05-13 | — | — | EP | disclosed |
| EP-0212989-B1 | LIPID VESICLES CONTAINING LABELED SPECIES AND THEIR ANALYTICAL USES | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1992-02-19 | — | — | EP | disclosed |
| EP-0465581-A1 | ERYTHROMYCIN DERIVATIVES. | ABBOTT LAB (US) | 1992-01-15 | — | — | EP | disclosed |
| US-5068342-A | Hypoglycemic agents and antidiabetic agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1991-11-26 | — | — | US | disclosed |
| US-5047410-A | Indolyl derivatives and their use as 5-HT3, receptor antagonists | ISTITUTO DE ANGELI S.P.A. (IT) | 1991-09-10 | — | — | US | disclosed |
| US-5030721-A | For colorimetric analysis of glycosides | KIKKOMAN CORPORATION (JP) | 1991-07-09 | — | — | US | disclosed |
| US-4997948-A | Hypoglycemic agents | AMERICAN HOME PRODUCTS (US) | 1991-03-05 | — | — | US | disclosed |
| CN-1047672-A | PYRANYL CYANOGUANIDINE DERIVATIVES | SQUIBB & SONS INC (US) | 1990-12-12 | — | — | CN | disclosed |
| EP-0401010-A2 | Pyranyl cyanoguanidine derivatives | E.R. Squibb & Sons, Inc. (US) | 1990-12-05 | — | — | EP | disclosed |
| US-4925774-A | DEPOSITING TETRACYANOQUINODIMETHAN COMPOUND | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1990-05-15 | — | — | US | disclosed |
| US-4925968-A | ANTIDIABETIC AGENTS; CHEMICAL INTERMEDIATES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1990-05-15 | — | — | US | disclosed |
| CN-1040200-A | ANTIMICROBIAL AGENT FOR ANIMALS | DAIICHI SEIYAKU CO (JP) | 1990-03-07 | — | — | CN | disclosed |
| EP-0354453-A2 | Antimicrobial agent for animals | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1990-02-14 | — | — | EP | disclosed |
| US-4895853-A | Antitumor alkaloids | HARBOR BRANCH OCEANOGRAPHIC INSTITUTION, INC. (US) | 1990-01-23 | — | — | US | disclosed |
| EP-0351385-A2 | New amidino and guanidino derivatives | BOEHRINGER INGELHEIM ITALIA S.p.A. (IT) | 1990-01-17 | — | — | EP | disclosed |
| CN-1038645-A | 3-tetramethyleneimine sulfenyl-1-azabicyclic \" 3,2,0 \" hept-2-ene\"-2-carboxylic acid derivative and method for making thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1990-01-10 | — | — | CN | disclosed |
| US-4886810-A | ANTIBACTERIAL | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1989-12-12 | — | — | US | disclosed |
| US-4843062-A | TREATING CATARACTS OR NERVOUS SYSTEM DISORDERS IN DIABETICS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1989-06-27 | — | — | US | disclosed |
| US-4837235-A | ANTIALLERGENS, ANTIINFLAMMATORY AGENTS | ICI AMERICAS INC. (US) | 1989-06-06 | — | — | US | disclosed |
| US-4822788-A | MICROBIOCIDES, BETA-LACTAMASE INHIBITORS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-04-18 | — | — | US | disclosed |
| US-4822790-A | ANTIMICROBIOCIDES OR BETA-LACTAMASE INHIBITORS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-04-18 | — | — | US | disclosed |
| US-4808596-A | STORAGE STABLE, ANTIULCER AGENTS | TOKYO TANABE COMPANY, LTD. (JP) | 1989-02-28 | — | — | US | disclosed |
| EP-0302599-A2 | Bicyclo-octane and bicyclo-nonane derivatives, processes for their preparation and their use as herbicides | HER MAJESTY THE QUEEN IN RIGHT OF NEW ZEALAND, DEPARTMENT OF SCIENTIFIC AND INDUSTRIAL RESEARCH, CHEMISTRY DIVISON (NZ) | 1989-02-08 | — | — | EP | disclosed |
| US-4800201-A | 1,4-thiazine derivative, and cardiotonic agent comprising it as effective component | ZENYAKU KOGYO KABUSHIKI KAISHA (JP) | 1989-01-24 | — | — | US | disclosed |
| US-4788302-A | TISSUE EXTRACT FROM L. VIRGULATA OR R. REINFORMIS | DUKE UNIVERSITY (US) | 1988-11-29 | — | — | US | disclosed |
| US-4788302-A | TISSUE EXTRACT FROM L. VIRGULATA OR R. REINFORMIS | DUKE UNIVERSITY (US) | 1988-11-29 | — | — | US | disclosed |
| US-4782147-A | ANTIBIOTIC | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1988-11-01 | — | — | US | disclosed |
| US-4769467-A | Fluorogenic 2,1,3-benzoxadiazoles and fluorometric amine/thiol assays therewith | OREAD LABORATORIES, INC. (US) | 1988-09-06 | — | — | US | disclosed |
| EP-0115416-B1 | TRIAZOLE ANTIFUNGAL AGENTS | Pfizer Limited (GB) | 1988-06-29 | — | — | EP | disclosed |
| EP-0272056-A1 | New antitumor alkaloids | HARBOR BRANCH OCEANOGRAPHIC INSTITUTION, INC. (US) | 1988-06-22 | — | — | EP | disclosed |
| CN-87106681-A | Siloxanes (methyl) acrylate that contains tricyclodecane groups | — | 1988-04-20 | — | — | CN | disclosed |
| EP-0138302-B1 | PYRAZOLO(3,4,5-KL)ACRIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND PROCESSES FOR THEIR PRODUCTION | WARNER-LAMBERT COMPANY (US) | 1988-03-09 | — | — | EP | disclosed |
| US-4725607-A | MITICIDES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-02-16 | — | — | US | disclosed |
| CN-87103138-A | New quinoline and preparation method thereof | — | 1987-11-04 | — | — | CN | disclosed |
| EP-0242789-A2 | Novel quinoline derivates and processes for preparation thereof | Dainippon Pharmaceutical Co., Ltd. (JP) | 1987-10-28 | — | — | EP | disclosed |
| CN-86101774-A | The Pasteurisation process of plasma protein or blood plasma fractions | — | 1987-10-07 | — | — | CN | disclosed |
| EP-0103381-B1 | SUBSTITUTED ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONES | WARNER-LAMBERT COMPANY (US) | 1987-09-23 | — | — | EP | disclosed |
| US-4695535-A | ACYCLIC THIOETHER, SILVER HALIDE CRYSTAL GROWTH | EASTMAN KODAK COMPANY (US) | 1987-09-22 | — | — | US | disclosed |
| EP-0233287-A1 | 1,4-THIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND CARDIOTONICS CONTAINING THE SAME | ZENYAKU KOGYO KABUSHIKIKAISHA (JP) | 1987-08-26 | — | — | EP | disclosed |
| EP-0227241-A2 | Medicinal indole and indazole keto sulphone derivatives | ZENECA INC. (US) | 1987-07-01 | — | — | EP | disclosed |
| US-4672123-A | AFFECT NEUROMUSCULAR IMPULSE TRANSMISSION; TOXIC; CHEMICAL WARFARE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1987-06-09 | — | — | US | disclosed |
| EP-0216541-A1 | Aryl pyridones | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-04-01 | — | — | EP | disclosed |
| EP-0212989-A2 | Lipid vesicles containing labeled species and their analytical uses | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1987-03-04 | — | — | EP | disclosed |
| EP-0081955-B1 | BENZO-FUSED HETEROCYCLIC COMPOUNDS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1987-01-21 | — | — | EP | disclosed |
| US-4621086-A | Method of treating leukemia with pyrazolo[3,4,5-kl]acridines | WARNER-LAMBERT COMPANY (US) | 1986-11-04 | — | — | US | disclosed |
| US-4613674-A | FIREPROOFING | TSOLIS ALEXANDROS K | 1986-09-23 | — | — | US | disclosed |
| US-4588730-A | Pyrazolo[3,4,5-k1]acridine compositions and methods for their use as antimicrobials | WARNER-LAMBERT COMPANY (US) | 1986-05-13 | — | — | US | disclosed |
| US-4560697-A | ANTIPROTOZOA AGENT FOR PLANTS, ANIMALS | PFIZER INC. (US) | 1985-12-24 | — | — | US | disclosed |
| EP-0163458-A1 | Tetrahydronaphthalenols for the treatment of hypertension | E.R. Squibb & Sons, Inc. (US) | 1985-12-04 | — | — | EP | disclosed |
| US-4556654-A | ANTICARCINOGENIC, FUNGICIDES, ANTISEPTICS | WARNER-LAMBERT COMPANY (US) | 1985-12-03 | — | — | US | disclosed |
| US-4555572-A | Pyrazolo[3,4,5-kl]acridine compositions and methods for their production and use | WARNER-LAMBERT COMPANY (US) | 1985-11-26 | — | — | US | disclosed |
| US-4550105-A | BETA-LACTAMASE INHIBITORS, ANTIBIOTICS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1985-10-29 | — | — | US | disclosed |
| US-4532336-A | Antibiotics | THE UPJOHN COMPANY (US) | 1985-07-30 | — | — | US | disclosed |
| EP-0138302-A1 | Pyrazolo(3,4,5-kl)acridine compounds, pharmaceutical compositions comprising the same and processes for their production | WARNER-LAMBERT COMPANY (US) | 1985-04-24 | — | — | EP | disclosed |
| US-4490527-A | Benzo-fused heterocyclic anti-ulcer agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1984-12-25 | — | — | US | disclosed |
| EP-0115416-A2 | Triazole antifungal agents | Pfizer Limited (GB) | 1984-08-08 | — | — | EP | disclosed |
| US-4464299-A | Antibacterial carbapenem compounds | SHIONOGI & CO., LTD. (JP) | 1984-08-07 | — | — | US | disclosed |
| EP-0042161-B1 | K-41.C(2) ESTERS AND COMPOSITIONS CONTAINING THEM | Shionogi & Co., Ltd. (JP) | 1984-05-09 | — | — | EP | disclosed |
| EP-0105735-A2 | Herbicidal ureas and process for preparation | UNION CARBIDE CORPORATION (US) | 1984-04-18 | — | — | EP | disclosed |
| EP-0103381-A1 | Substituted anthra(1,9-cd)pyrazol-6(2H)-ones | WARNER-LAMBERT COMPANY (US) | 1984-03-21 | — | — | EP | disclosed |
| EP-0026675-B1 | 1-AZAXANTHONE-3-CARBOXYLIC ACIDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Takeda Chemical Industries, Ltd. (JP) | 1984-03-14 | — | — | EP | disclosed |
| US-4431596-A | REACTING GLYOXAL WITH PHOSPHOROUS ACID COMPOUNDS | TSOLIS ALEXANDROS K | 1984-02-14 | — | — | US | disclosed |
| US-4426519-A | ANTIBIOTICS | ROUSSEL UCLAF (FR) | 1984-01-17 | — | — | US | disclosed |
| US-4424212-A | MITICIDES, ANTIPROTOZOA AGENTS, COCCIDIOSIS, POLYETHER ANTIBIOTICS | SHIONOGI & CO., LTD. (JP) | 1984-01-03 | — | — | US | disclosed |
| US-4411904-A | Diphenylpropanamines, compositions thereof and use thereof | WARNER-LAMBERT COMPANY (US) | 1983-10-25 | — | — | US | disclosed |
| US-4394312-A | Process for preparing rifamycin derivatives | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1983-07-19 | — | — | US | disclosed |
| EP-0081955-A2 | Benzo-fused heterocyclic compounds | AMERICAN HOME PRODUCTS CORPORATION (US) | 1983-06-22 | — | — | EP | disclosed |
| EP-0044085-B1 | NOVEL NUCLEOSIDE DERIVATIVES | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1983-05-25 | — | — | EP | disclosed |
| US-4367332-A | N4 -Alkoxycarbonylarabinofuranosylcytosine | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1983-01-04 | — | — | US | disclosed |
| US-4364954-A | NEUROLEPTIC AGENT | WARNER-LAMBERT COMPANY (US) | 1982-12-21 | — | — | US | disclosed |
| US-4362866-A | BACTERICIDES | SHIONOGI & CO., LTD. (JP) | 1982-12-07 | — | — | US | disclosed |
| US-4328225-A | ANTIBIOTIC | ROUSSEL UCLAF (FR) | 1982-05-04 | — | — | US | disclosed |
| EP-0042161-A1 | K-41.C(2) Esters and compositions containing them | Shionogi & Co., Ltd. (JP) | 1981-12-23 | — | — | EP | disclosed |
| US-4304926-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1981-12-08 | — | — | US | disclosed |
| US-4302463-A | ANTIALLERGENS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1981-11-24 | — | — | US | disclosed |
| US-4292321-A | 1,3,8-Triazaspirodecane-4-ones, pharmaceutical compositions thereof and method of use thereof | WARNER-LAMBERT COMPANY (US) | 1981-09-29 | — | — | US | disclosed |
| EP-0026675-A1 | 1-Azaxanthone-3-carboxylic acids, their preparation and pharmaceutical compositions containing them | Takeda Chemical Industries, Ltd. (JP) | 1981-04-08 | — | — | EP | disclosed |
| US-4209526-A | Antiviral arylenedioxyalkyl substituted pyrazoles | STERLING DRUG INC. (US) | 1980-06-24 | — | — | US | disclosed |
| US-4175053-A | Base reactant | THE PROCTER & GAMBLE COMPANY (US) | 1979-11-20 | — | — | US | disclosed |
| US-4171365-A | Antiviral aryloxyalkylpyrazoles | STERLING DRUG INC. (US) | 1979-10-16 | — | — | US | disclosed |
| EP-0001774-A1 | Derivatives of BPTI (basic pancreatic trypsin-inhibitor), process for their preparation and their use as medicines | BAYER AG (DE) | 1979-05-16 | — | — | EP | disclosed |
| US-4096280-A | Arylenedioxy-bis-diketones | STERLING DRUG INC. (US) | 1978-06-20 | — | — | US | disclosed |
| US-4058551-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1977-11-15 | — | — | US | disclosed |
| US-4048191-A | Halo-substituted 1-loweralkyl-5-aroylpyrrole-2-acetic acid compounds | MCNEIL LABORATORIES, INCORPORATED (US) | 1977-09-13 | — | — | US | disclosed |
| US-4043979-A | Polymer-multiheteromacrocycles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1977-08-23 | — | — | US | disclosed |
| US-4042606-A | PROSTAGLANDIN ENANTIOMORPHS | THE UPJOHN COMPANY (US) | 1977-08-16 | — | — | US | disclosed |
| US-4042472-A | Electrolytic process for 7-methoxy-3-exomethylenecepham compounds | ELI LILLY AND COMPANY (US) | 1977-08-16 | — | — | US | disclosed |
| US-4013707-A | PROSTAGLANDINS, ANTISPASMODIC, ANTIASTHMA, HYPOTENSIVE | THE UPJOHN COMPANY (US) | 1977-03-22 | — | — | US | disclosed |
| US-4013693-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1977-03-22 | — | — | US | disclosed |
| US-4002616-A | POLYESTERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-01-11 | — | — | US | disclosed |
| US-4000275-A | BENZIMIDAZO(2,1-B) QUINAZOLIN-12(6H)ONES | ELI LILLY AND COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
| US-3989689-A | ANTIINFLAMMATORY | CIBA-GEIGY CORPORATION (US) | 1976-11-02 | — | — | US | disclosed |
| US-3979440-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-09-07 | — | — | US | disclosed |
| US-3969464-A | PROSTAGLANDIN | THE UPJOHN COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3962289-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3962220-A | ONE-STEP, AROMATIC ALDEHYDES, ACETIC ACID | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3962221-A | CONDENSATION, REDUCTION, OXIDATION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3952048-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-04-20 | — | — | US | disclosed |
| US-3949081-A | 4-Carbamoyl-1-benzazepines as antiinflammatory agents | CIBA-GEIGY CORPORATION (US) | 1976-04-06 | — | — | US | disclosed |
| US-3948970-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-04-06 | — | — | US | disclosed |
| US-3932486-A | GASTRIC SECRETION INHIBITORS, ANTISPASMODIC, ANTIASTHMATIC, HYPOTENSIVE | THE UPJOHN COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
| US-3931281-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
| US-3931281-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-01-06 | — | — | US | disclosed |